Catalysts and processes for the hydrogenation of amides

Abstract

There is provided a process for the reduction of one or more amide moieties in a compound comprising contacting the compound with hydrogen gas and a transition metal catalyst in the presence or absence of a base under conditions for the reduction an amide bond. The presently described processes can be performed at low catalyst loading using relatively mild temperature and pressures, and optionally, in the presence or absence of a base or high catalyst loadings using low temperatures and pressures and high loadings of base to effect dynamic kinetic resolution of achiral amides.

Claims

1. A process for the reduction of an amide bond in a substrate comprising contacting the substrate with: hydrogen gas; and a transition metal catalyst complex comprising a transition metal selected from Ru, Fe, Rh, Ir, Pd, Cu, Co, Pt, Ti, Zr, Os or Hf, and at least one to four ligands selected from the group consisting of: a bidentate diamino (N—N) ligand; a bidentate aminophosphine (P—N) ligand; a tridentate diaminophosphine (P—N—N) ligand; a tridentate aminodiphosphine (P—N—P) ligand; and a tetradentate diamino-diphosphine (P—N—N—P) ligand, and a monodentate amine (N) ligand; under conditions suitable to cleave the amide bond to give an amine and an alcohol; wherein said process is performed in one of the presence of a base or in the absence of base and wherein, when said process is performed in the absence of base, the process is performed in the presence of a sufficiently non-basic hydridic species, and wherein when said process is performed in the presence of a base, and the transition metal catalyst complex is present at an amount of 1 mol % or more, the process is performed using hydrogen gas at a pressure less than 10 atm; and wherein if the transition metal catalyst complex is cationic, the transition metal catalyst complex further comprises one or more suitable counteranions.

2. The process of claim 1, wherein the transition metal catalyst complex additionally comprises one or more ligands selected from the group consisting of a hydride ligand, a neutral monodentate ligand, and an anionic monodentate ligand.

3. The process of claim 1, wherein the bidentate diamino (N—N) ligand is ##STR00057##

4. The process of claim 1, wherein the bidentate aminophosphine (P—N) ligand has the Formula (X)
PR.sup.36R.sup.36CHR.sup.35CHR.sup.35NH.sub.2  (X) wherein each R.sup.35 is independently H, (C.sub.1-10)alkyl, (C.sub.1-10)alkyl fluoro-substituted (C.sub.1-4)-alkyl, halo, (C.sub.1-10)cycloalkyl, fluoro-substituted (C.sub.1-10)cycloalkyl, (C.sub.1-10)-alkoxy, fluoro-substituted (C.sub.1-10)-alkoxy, unsubstituted and substituted phenyl and substituted and unsubstituted naphthyl, or adjacent substituents are joined together to form, including the carbon atoms to which they are attached, one or more unsubstituted or substituted phenylene, cyclohexylene, naphthylene, pyridylene or ferrocenylene groups, and each R.sup.36 is independently (C.sub.4-10) alkyl, (C.sub.4-10) cycloalkyl, or phenyl, each of which may be optionally substituted.

5. The process of claim 1, wherein the transition metal catalyst complex is: ##STR00058## trans-[Ru((R)-BINAP)(H).sub.2((R,R)-dpen)], [Ru(Cl).sub.2(Ph.sub.2P(CH.sub.2).sub.2NH.sub.2).sub.2], [Ru(Ph.sub.2P CH.sub.2CH.sub.2NH.sub.2).sub.2 (η.sup.3-C.sub.3H.sub.5)]BF.sub.4, trans-[Ru(H).sub.2 (Ph.sub.2P(CH.sub.2).sub.2NH.sub.2).sub.2], [Ru(H)(Ph.sub.2P(CH.sub.2).sub.2NH.sub.2) (Ph.sub.2P(CH.sub.2).sub.2NH)], [Ru(Cl).sub.2(Cy.sub.2PCH.sub.2CH.sub.2NH.sub.2).sub.2] (Cy=cyclohexyl), or an isomer thereof.

6. The process of claim 1 wherein the transition metal catalyst complex is chiral.

7. The process of claim 1, wherein the process of the amide bond cleavage of the substrate produces: products that are enantiomerically enriched; and/or a chiral product.

8. The process of claim 1, wherein: (i) the process is performed in a solvent selected from tetrahydrofuran (THF), diethyl ether, chlorinated solvents, toluene and mixtures thereof; (ii) the hydrogen gas is used at a pressure in the range of from about 1 atm to about 100 atm or at a pressure under about 50 atm; or (iii) the process is performed in the presence of a base, and the transition metal catalyst complex is present at an amount of: a) 1 mol % or less; b) about 0.5 mol % or less; c) about 0.1 mol % or less; or d) from about 0.1 mol % to about 0.01 mol %.

9. The process of claim 8, wherein the process is performed at a temperature of 100° C. or less and the hydrogen gas is used at a pressure of 50 atm or less.

10. The process of claim 1, wherein the process is performed in the presence of a base, the transition metal catalyst complex is present at an amount less than about 10 mol %, the hydrogen gas is used at a pressure of about 4 atm or less and the process is carried out at a temperature of 0° C. or higher.

11. The process of claim 8, wherein the base is an organic non-coordinating base, a carbonate salt, a carboxylate salt, an alcoholate salt, a hydroxide salt, or a silazine salt.

12. The process of claim 11, wherein the base is tBuOK, or [(CH.sub.3).sub.3Si].sub.2NK.

13. The process of claim 1, wherein the process is performed in the absence of base, and the hydrogen gas is used at a pressure less than about 10 atm, or less than about 5 atm, and, optionally, at a temperature of from about −50° C. to about 150° C.

14. A process for the reduction of an amide bond in a substrate comprising: contacting the substrate with hydrogen gas and a transition metal catalyst complex under conditions suitable to cleave the amide bond to give an amine and an alcohol, wherein the transition metal catalyst complex comprises at least one bidentate aminophosphine (P—N) ligand having the Formula (X)
PR.sup.36R.sup.36CHR.sup.35CHR.sup.35NH.sub.2  (X) wherein each R.sup.35 is independently H, (C.sub.1-10)alkyl, (C.sub.1-10)alkyl fluoro-substituted (C.sub.1-4)-alkyl, halo, (C.sub.1-10)cycloalkyl, fluoro-substituted (C.sub.1-10)cycloalkyl, (C.sub.1-10)-alkoxy, fluoro-substituted (C.sub.1-10)-alkoxy, unsubstituted and substituted phenyl and substituted and unsubstituted naphthyl, or adjacent substituents are joined together to form, including the carbon atoms to which they are attached, one or more unsubstituted or substituted phenylene, cyclohexylene, naphthylene, pyridylene or ferrocenylene groups, and each R.sup.36 is independently (C.sub.4-10) alkyl, (C.sub.4-10) cycloalkyl, or phenyl, each of which may be optionally substituted.

15. The process of claim 14 wherein the transition metal catalyst complex is ##STR00059## [Ru(Cl).sub.2(Ph.sub.2P(CH.sub.2).sub.2NH.sub.2).sub.2], [Ru(Ph.sub.2P CH.sub.2CH.sub.2NH.sub.2).sub.2(η.sup.3-C.sub.3H.sub.5)]BF.sub.4, trans-[Ru(H).sub.2(Ph.sub.2P(CH.sub.2).sub.2NH.sub.2).sub.2], [Ru(H)(Ph.sub.2P(CH.sub.2).sub.2NH.sub.2) (Ph.sub.2P(CH.sub.2).sub.2NH)], [Ru(Cl).sub.2(Cy.sub.2PCH.sub.2CH.sub.2NH.sub.2).sub.2] (Cy=cyclohexyl), or an isomer thereof.

16. The process of claim 14, wherein: (i) the substrate is chiral; (ii) the process produces products that are enantiomerically enriched, and/or (iii) the process produces a chiral product.

17. The process of claim 14, wherein: (i) the process is performed in a solvent selected from tetrahydrofuran (THF), diethyl ether, chlorinated solvents, toluene and mixtures thereof; (ii) the hydrogen gas is used at a pressure in the range of from about 1 atm to about 100 atm, or (iii) the process is performed in the presence of a base and the transition metal catalyst complex is present at an amount of 1 mol % or less.

18. The process of claim 14, wherein the process is performed in the presence of a base, the transition metal catalyst complex is present at an amount less than about 10 mol %, the hydrogen gas is used at a pressure of about 4 atm or less and the process is carried out at a temperature of 0° C. or higher.

19. The process of claim 17, wherein the base is an organic non-coordinating base, a carbonate salt, a carboxylate salt, an alcoholate salt, a hydroxide salt, or a silazine salt.

20. The process of claim 19, wherein the base is tBuOK or [(CH.sub.3).sub.3Si].sub.2NK.

21. The process of claim 14, wherein: (i) the transition metal catalyst complex is present at an amount of about 0.5 mol % or less, or about 0.1 mol % or less or from about 0.1 mol % to about 0.01 mol %; (ii) the process is performed at a temperature of 100° C. or less and the hydrogen gas is used at a pressure of 50 atm or less; (iii) the process is performed in the absence of base and the hydrogen gas is used at a pressure less than about 10 atm, or less than about 5 atm; and/or (iv) the process is performed at a temperature of from about −50° C. to about 150° C.

22. The process of claim 10, wherein the process is carried out at a temperature of from about 22° C. to about 0° C.

Description

BRIEF DESCRIPTION OF THE FIGURES

(1) For a better understanding of the present invention, as well as other aspects and further features thereof, reference is made to the following description which is to be used in conjunction with the accompanying drawings, where:

(2) FIG. 1 depicts the reaction between 2 equivalents of Ph.sub.2P(CH.sub.2).sub.2NH.sub.2 and cis-[Ru(CH.sub.3CN).sub.2(η.sup.3-C.sub.3H.sub.5)(COD)]BF.sub.4 (COD=1,5-cyclooctadiene) to form a highly active catalyst precursor for the selective hydrogenation of amides;

(3) FIG. 2 graphically depicts the .sup.31P {.sup.1H} NMR spectrum of [Ru(η.sup.3-C.sub.3H.sub.5)(Ph.sub.2PCH.sub.2CH.sub.2NH.sub.2).sub.2]BF.sub.4 (5) in CD.sub.2Cl.sub.2;

(4) FIG. 3 graphically depicts the .sup.31P{.sup.1H} and .sup.31P NMR spectra of [Ru(η.sup.3-C.sub.3H.sub.5)(Ph.sub.2PCH.sub.2CH.sub.2NH.sub.2).sub.2]BF.sub.4 (5);

(5) FIG. 4 graphically depicts the preliminary .sup.31P {.sup.1H} NMR Study on the reactivity of (5) towards H.sub.2 and Base in THF;

(6) FIG. 5 graphically depicts preliminary .sup.1H NMR Study on the reactivity of (5) towards H.sub.2 and Base in THF;

(7) FIG. 6 graphically depicts the comparison of the hydride regions between (5) and (2) in THF-d.sub.8;

(8) FIG. 7 graphically depicts the .sup.1H NMR of the hydrogenation reaction of N-Phenylpyrrolidin-2-one (2c);

(9) FIG. 8 graphically depicts the .sup.1H NMR of the hydrogenation reaction of N-Methylpyrrolidin-2-one (2d);

(10) FIG. 9 graphically depicts the .sup.1H NMR of the hydrogenation reaction of N-Phenylpiperidone (6);

(11) FIG. 10 graphically depicts the .sup.1H NMR of the hydrogenation reaction of ε-Caprolactam (7);

(12) FIG. 11 graphically depicts the .sup.1H NMR of the hydrogenation reaction of N,N-Diphenylbenzamide (8a), wherein trace benzyl benzoate formed is notated as (+);

(13) FIG. 12 graphically depicts the .sup.1H NMR of the hydrogenation reaction of N-Methyl-N-Phenylbenzamide (8b);

(14) FIG. 13 graphically depicts the .sup.1H NMR of the hydrogenation reaction of N,N-Dimethylbenzamide (8c);

(15) FIG. 14 graphically depicts the .sup.1H NMR of the hydrogenation reaction of 1-Benzoylpiperidine (8d);

(16) FIG. 15 graphically depicts the .sup.1H NMR of the hydrogenation reaction of Benzanilide (8e);

(17) FIG. 16 graphically depicts the .sup.1H NMR of the hydrogenation reaction of N-Methylbenzamide (80;

(18) FIG. 17 graphically depicts the .sup.1H NMR of the hydrogenation reaction of N,N-Diphenylacetamide (8g);

(19) FIG. 18 graphically depicts the .sup.1H NMR of the hydrogenation reaction of N-Methylacetanilide (8h);

(20) FIG. 19 graphically depicts the .sup.1H NMR of the hydrogenation reaction of N,N-Dimethylacetamide (8i), wherein anthracene is used as an internal standard, notated as (^); and

(21) FIG. 20 graphically depicts the .sup.1H NMR of the hydrogenation reaction of acetanilide (8j).

DETAILED DESCRIPTION

Definitions

(22) Unless defined otherwise, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs.

(23) As used in the specification and claims, the singular forms “a”, “an” and “the” include plural references unless the context clearly dictates otherwise.

(24) The term “comprising” as used herein will be understood to mean that the list following is non-exhaustive and may or may not include any other additional suitable items, for example one or more further feature(s), component(s) and/or ingredient(s) as appropriate.

(25) As used herein, “alkyl” refers to a linear, branched or cyclic, saturated hydrocarbon group which can be unsubstituted or optionally substituted with one or more substituent. Examples of saturated straight or branched chain alkyl groups include, but are not limited to, methyl, ethyl, 1-propyl, 2-propyl, 1-butyl, 2-butyl, 2-methyl-1-propyl, 2-methyl-2-propyl, 1-pentyl, 2-pentyl, 3-pentyl, 2-methyl-1-butyl, 3-methyl-1-butyl, 2-methyl-3-butyl, 2,2-dimethyl-1-propyl, 1-hexyl, 2-hexyl, 3-hexyl, 2-methyl-1-pentyl, 3-methyl-1-pentyl, 4-methyl-1-pentyl, 2-methyl-2-pentyl, 3-methyl-2-pentyl, 4-methyl-2-pentyl, 2,2-dimethyl-1-butyl, 3,3-dimethyl-1-butyl and 2-ethyl-1-butyl, 1-heptyl and 1-octyl. As used herein the term “alkyl” encompasses cyclic alkyls, or cycloalkyl groups. The term “cycloalkyl” as used herein refers to a non-aromatic, saturated monocyclic, bicyclic or tricyclic hydrocarbon ring system containing at least 3 carbon atoms. Examples of C.sub.3-C.sub.12 cycloalkyl groups include, but are not limited to, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, norbornyl, adamantyl, bicyclo[2.2.2]oct-2-enyl, and bicyclo[2.2.2]octyl.

(26) The term “(C.sub.1-n)-alkyl” as used herein refers to straight and/or branched chain, saturated alkyl radicals containing from one to “n” carbon atoms and includes (depending on the identity of n) methyl, ethyl, propyl, isopropyl, n-butyl, s-butyl, isobutyl, t-butyl, 2,2-dimethylbutyl, n-pentyl, 2-methylpentyl, 3-methylpentyl, 4-methylpentyl, n-hexyl and the like, where the variable n is an integer representing the largest number of carbon atoms in the alkyl radical.

(27) The term “(C.sub.3-n)-cycloalkyl” as used herein refers to a monocyclic or polycyclic saturated carbocyclic group containing from three to n carbon atoms and includes (depending on the identity of n) cyclopropyl, cyclobutyl, cyclopentyl, cyclodecyl, bicyclo[2.2.2]octane, bicyclo[2.2.1]heptane, bicyclo[3.1.1]heptane and the like, where the variable n is an integer representing the largest number of carbon atoms in the cycloalkyl radical.

(28) As used herein, the term “alkenyl” refers to a straight, branched or cyclic hydrocarbon group containing at least one double bond which can be unsubstituted or optionally substituted with one or more substituents.

(29) The term “(C.sub.2-n)-alkenyl” as used herein refers to straight and/or branched chain, unsaturated alkyl radicals containing from two to n carbon atoms and one or more, suitably one to three, double bonds, and includes (depending on the identity of n) vinyl, allyl, 2-methylprop-1-enyl, but-1-enyl, but-2-enyl, but-3-enyl, 2-methylbut-1-enyl, 2-methylpent-1-enyl, 4-methylpent-1-enyl, 4-methylpent-2-enyl, 2-methylpent-2-enyl, 4-methylpenta-1,3-dienyl, hexen-1-yl and the like, where the variable n is an integer representing the largest number of carbon atoms in the alkenyl radical.

(30) The term “(C.sub.3-n)-cycloalkenyl” as used herein refers to a monocyclic or polycyclic carbocyclic group containing from three to n carbon atoms (depending on the identity of n) and one or more, suitably one or two, double bonds and includes cyclopropenyl, cyclobutenyl, cyclopentenyl, cyclodecenyl, bicyclo[2.2.2]oct-2-ene, bicyclo[2.2.1]hept-2-ene, bicyclo[3.1.1]hept-2-ene and the like, where the variable n is an integer representing the largest number of carbon atoms in the cycloalkenyl radical.

(31) As used herein, “alkynyl” refers to an unsaturated, straight or branched chain hydrocarbon group containing at least one triple bond which can be unsubstituted or optionally substituted with one or more substituents.

(32) The term “(C.sub.2-n)-alkynyl” as used herein refers to straight and/or branched chain, unsaturated alkyl groups containing from one to n carbon atoms and one or more, suitably one to three, triple bonds, and includes (depending on the identity of n) ethynyl, 1-propynyl, 2-propynyl, 2-methylprop-1-ynyl, 1-butynyl, 2-butynyl, 3-butynyl, 1,3-butadiynyl, 3-methylbut-1-ynyl, 4-methylbut-ynyl, 4-methylbut-2-ynyl, 2-methylbut-1-ynyl, 1-pentynyl, 2-pentynyl, 3-pentynyl, 4-pentynyl, 1,3-pentadiynyl, 1,4-pentadiynyl, 3-methylpent-1-ynyl, 4-methylpent-2-ynyl, 4-methylpent-2-ynyl, 1-hexynyl and the like, where the variable n is an integer representing the largest number of carbon atoms in the alkynyl radical.

(33) The term “(C.sub.3-n)-cycloalkynyl” as used herein refers to a monocyclic or polycyclic carbocyclic group containing from three to n carbon atoms (depending on the identity of n) and one or more, suitably one or two, double bonds and includes cyclopropenyl, cyclobutynyl, cyclopentynyl, cyclohexynyl, cyclodecynyl, bicyclo[2.2.2]oct-2-yne, bicyclo[2.2.1]hept-2-yne, bicyclo[3.1.1]hept-2-yne and the like, where the variable n is an integer representing the largest number of carbon atoms in the cycloalkynyl radical.

(34) As used herein, “aryl” refers to hydrocarbons derived from benzene or a benzene derivative that are unsaturated aromatic carbocyclic groups of from 6 to 100 carbon atoms, or from which may or may not be a fused ring system, in some embodiments 6 to 50, in other embodiments 6 to 25, and in still other embodiments 6 to 15. The aryls may have a single or multiple rings. The term “aryl” as used herein also includes substituted aryls. Examples include, but are not limited to phenyl, naphthyl, xylene, phenylethane, substituted phenyl, substituted naphthyl, substituted xylene, substituted phenylethane and the like. As used herein, “heteroaryl” refers to an aryl that includes from 1 to 10, in other embodiments 1 to 4, heteroatoms such as but not limited to oxygen, nitrogen and sulfur. The heteroaryl may be substituted or unsubstituted.

(35) The term “(C.sub.6-n)-aryl” as used herein refers to a monocyclic, bicyclic or tricyclic carbocyclic ring system containing from 6 to n carbon atoms and optionally a metal and includes, depending on the identity of n, phenyl, naphthyl, anthracenyl, 1,2-dihydronaphthyl, 1,2,3,4-tetrahydronaphthyl, fluorenyl, indanyl, indenyl, ferrocenyl, and the like, where the variable n is an integer representing the largest number of carbon atoms in the aryl radical.

(36) As used herein, a “heteroatom” refers to an atom that is not carbon or hydrogen, such as nitrogen, oxygen, sulfur, phosphorus, chlorine, bromine, and iodine.

(37) As used herein, the terms “heterocycle” and “heteroaryl” refer to an aromatic or nonaromatic monocyclic or bicyclic ring of carbon atoms and from 1 to 5 heteroatoms selected from oxygen, nitrogen and sulfur, and which can be substituted or unsubstituted. Included within the term “heterocycle” are heteroaryls, as defined above. Examples of 3- to 9-membered heterocycles include, but are not limited to, aziridinyl, oxiranyl, thiiranyl, azirinyl, diaziridinyl, diazirinyl, oxaziridinyl, azetidinyl, azetidinonyl, oxetanyl, thietanyl, piperidinyl, piperazinyl, morpholinyl, pyrrolyl, oxazinyl, thiazinyl, diazinyl, triazinyl, tetrazinyl, imidazolyl, benzimidazolyl, tetrazolyl, indolyl, isoquinolinyl, quinolinyl, quinazolinyl, pyrrolidinyl, purinyl, isoxazolyl, benzisoxazolyl, furanyl, furazanyl, pyridinyl, oxazolyl, benzoxazolyl, thiazolyl, benzthiazolyl, thiophenyl, pyrazolyl, triazolyl, benzodiazolyl, benzotriazolyl, pyrimidinyl, isoindolyl and indazolyl.

(38) As used herein, “substituted” refers to the structure having one or more substituents. A substituent is an atom or group of bonded atoms that can be considered to have replaced one or more hydrogen atoms attached to a parent molecular entity. Examples of substituents include aliphatic groups, halogen, arylcarbonyloxy, alkoxycarbonyloxy, aryloxycarbonyloxy, alkoxycarbonyl, aminocarbonyl, alkylthiocarbonyl, alkoxyl, phosphate ester, phosphonato, phosphinato, cyano, tertiary amino, tertiary acylamino, tertiary amide, imino, alkylthio, arylthio, sulfonato, sulfamoyl, tertiary sulfonamido, nitrile, trifluoromethyl, heterocyclyl, aromatic, and heteroaromatic moieties, ether, ester, boron-containing moieties, tertiary phosphines, and silicon-containing moieties.

(39) As used herein, “halogen” and “halo” refers to F, Cl, Br or I.

(40) The term “fluoro-substituted” with respect to any specified group as used herein indicates that one or more, including all, of the hydrogen atoms in the group have been replaced with fluorine, and includes trifluoromethyl, pentafluoroethyl, fluoromethyl and the like.

(41) The suffix “ene” added on to any of the above groups means that the group is divalent, i.e. inserted between two other groups.

(42) The term “ring system” as used herein refers to a carbon-containing ring system, that includes monocycles, fused bicyclic and polycyclic rings, bridged rings and metallocenes. Where specified, the carbons in the rings may be substituted or replaced with heteroatoms. The term “unsaturated” with respect to ring systems includes aromatic and nonaromatic rings.

(43) The terms “transition metal” and “suitable transition metal” as used herein refer to any transition metal that can be used to form a transition metal catalyst useful in the presently described process in the reduction of amides. These include, but are not limited to, Fe, Ru, Rh, Ir, Pd, Cu, Co, Pt, Ti, Zr, Os and Hf.

(44) The term “transition metal catalyst complex” as used herein refers to a complex comprising a transition metal catalyst, optionally also comprising one or more additional counteranion.

(45) As used herein, the term “transition metal catalyst” refers to the element of the transition metal catalyst complex that comprises the transition metal and its associated coordinated ligands. The transition metal catalyst is capable of binding hydride to form a transition metal hydride, which is the active catalyst. The active catalyst, which is capable of reducing an amide moiety, has at least one hydride ligand. It will be understood that more than four hydrogen atoms or hydrides can be coordinated to the transition metal to form a transition metal hydride that can act as a catalyst for the processes of the present disclosure.

(46) As used herein, the terms “suitable counteranion” and “counteranion” refer to a negatively charged ion that is optionally a part of the transition metal catalyst complex to charge balance a positively charged transition metal catalyst species. The counteranion is present in the transition metal catalyst complex when the transition metal catalyst is cationic, such that the total charge of transition metal catalyst complex is zero. It is understood that the counteranion is not reactive with the transition metal catalyst. Some examples of counteranions include, but are not limited to, OTf.sup.−, BF.sub.4.sup.− and PF.sub.6.sup.−.

(47) As used herein, the term “ligand” refers to the monodentate, bidentate, tridentate or tetradentate compound(s) which coordinate to the transition metal to form the transition metal catalyst. The presently described ligands may be chiral or achiral. In the case where the ligand is chiral, it is understood that the chiral atom may be present anywhere in the ligand molecule.

(48) The term “neutral monodentate ligand” as used herein refers to any neutral ligand which donates a single pair electrons and coordinates to the transition metal through a dative covalent bond. Some examples of neutral monodentate ligands include, but are not limited to, water, acetonitrile, DMF, ammonia, carbon monoxide, pyridine, tetrahydrofuran (THF), t-BuCN and t-BuNC.

(49) The term “anionic monodentate ligand” as used herein refers to any anionic ligand which donates a single pair electrons and coordinates to the transition metal. Examples of anionic monodentate ligands include, but are not limited to, halogens such as fluoro, chloro, bromo or iodo, (C.sub.1-6)-alkoxy, hydroxy, thiocyanate, cyano, carboxylate, sulfonates and nitrates.

(50) The terms “(P—P) ligand”, “(N—N) ligand”, “(P—N) ligand”, “(P—N—N) ligand”, “(P—N—P) ligand”, “(P—N—N—P) ligand”, “(P) ligand” and “(N) ligand” refer to ligands that can coordinate to the transition metal, wherein the capital letters in the brackets designate the atoms in each ligand, in series, that coordinate to the transition metal. For example, in the case of a (P—N—N) ligand, the ligand comprises a phosphorus atom, a first nitrogen atom and a second nitrogen atom connected in series with linker groups therebetween, wherein the phosphorus atom, first nitrogen atom and second nitrogen atom each form a dative covalent bond with the transition metal.

(51) As used herein, the terms “amide” and “amide bond” have their commonly understood meaning and refer to the bivalent functional group —N—CO—, or

(52) ##STR00007##

(53) As used herein, the term “cleave an amide bond” means that the C—N bond between the nitrogen and the carbonyl carbon in the amide bond is broken during the process of the reaction. Under the presently described process, the nitrogen and carbonyl group can be hydrogenated to give, respectively, an amine and an alcohol. The skilled worker will also appreciate that if the amide can also form the amino-alcohol and/or amine as it goes through the aldehyde or hemiaminal. Incomplete reductions are also possible, resulting in aldehydes, for example, which can undergo in situ reaction condensation reactions. The amide bond may be part of a linear or cyclic structure such that the reaction can result in a single compound having both an amine and an alcohol, or two separate compounds, one of which containing the amine and the other one having the alcohol.

(54) The terms “reduction” and “hydrogenation” as used herein refer to the cleavage reaction of the amide bond.

(55) As used herein, the term “dative covalent bond” refers to a coordinate bond wherein the shared pair of electrons that form the bond come from the same atom. In the present disclosure, the dative covalent bond occurs between the transition metal, e.g. ruthenium, and the coordinating atom.

(56) As used herein, a “coordinating atom” refers to an atom having a lone pair of electrons capable of coordinating, or forming a covalent dative bond with the transition metal.

(57) As used herein the term “base free” refers to a reaction that proceeds in the absence of base. Specifically, when the hydrogenation reaction is carried out in base, it is understood that the base participates in the reaction. The Applicant notes that a person of skill in the art would recognise that though BH.sub.4.sup.− is a weak base, it is not considered to be a strong enough base to assist in the hydrogenation reaction.

(58) Described herein are processes and catalysts for the hydrogenation of amides. Specifically, there is provided a process for the reduction of one or more amide moieties in a compound comprising contacting the compound with hydrogen gas and a catalyst comprising a transition metal hydride in the presence or absence of a base under conditions for the reduction of the one or more amide moieties to form a compound comprising amino alcohols and/or alcohols and amines.

(59) The presently described processes are characterized by the high activity of the catalysts in comparison to catalysts used in the past. Furthermore, the present processes can be performed at relatively low temperature and pressure, with relatively low catalyst loading, and optionally, in the absence of a base.

(60) Catalysts

(61) The transition metal catalyst can be a complex comprising a suitable transition metal, and coordinated thereto, one to four ligands selected from: (i) a bidentate diphosphine (P—P) ligand, (ii) a bidentate diamino (N—N) ligand, (iii) a bidentate aminophosphine (P—N) ligand, (iv) a tridentate diaminophosphine (P—N—N) ligand, (v) a tridentate aminodiphosphine (P—N—P) ligand, (vi) a tetradentate diaminodiphosphine (P—N—NP) ligand, (vii) a monodentate phoshine (P) ligand, and (viii) a monodentate amine ligand (N); one to three hydride ligands; zero to two neutral monodentate ligands; and zero to two anionic monodentate ligands, the complex being neutral or cationic, and if the complex is cationic, the complex further comprises one or more suitable counteranions.

(62) The transition metal can be Ru, Fe, Rh, Ir, Pd, Cu, Co, Pt, Ti, Zr, Os or Hf. In some examples the transition metal is Ru, Fe or Rh. In a specific example the transition metal is Ru.

(63) In some examples, the transition metal catalyst is selected from:

(64) ##STR00008##
trans-[Ru((R)-BINAP)(H).sub.2((R,R)-dpen)], [Ru(Cl).sub.2(Ph.sub.2P(CH.sub.2).sub.2NH.sub.2).sub.2], [Ru(COD)(Anthracene)]BF.sub.4, cis-[Ru(CH.sub.3CN).sub.2(η.sup.3-C.sub.3H.sub.5)(COD)]BF.sub.4, [Ru(Ph.sub.2PCH.sub.2CH.sub.2NH.sub.2).sub.2(η.sup.3-C.sub.3H.sub.5]BF.sub.4, trans-[Ru(H).sub.2(Ph.sub.2P(CH.sub.2).sub.2NH.sub.2).sub.2], [Ru(H)(Ph.sub.2P(CH.sub.2).sub.2NH.sub.2)(Ph.sub.2P(CH.sub.2).sub.2NH)], [Ru(Cl).sub.2(Cy.sub.2PCH.sub.2CH.sub.2NH.sub.2).sub.2] (Cy=cyclohexyl), or an isomer thereof.

(65) In some examples, the catalyst complex includes a counteranion such as, for example, OTf.sup.− or BF.sub.4.sup.− or PF.sub.6.sup.−.

(66) In one exemplary transition metal catalyst, a reaction between 2 equivalents of Ph.sub.2P(CH.sub.2).sub.2NH.sub.2 and cis-[Ru(CH.sub.3CN).sub.2(η.sup.3-C.sub.3H.sub.5)(COD)]BF.sub.4 (COD=1,5-cyclooctadiene) forms a the transition metal catalyst [Ru(η.sup.3-C.sub.3H.sub.5)(Ph.sub.2P(CH.sub.2).sub.2NH.sub.2).sub.2]BF.sub.4 (5), for the selective hydrogenation of amides. The dichloride analog [Ru(Cl).sub.2(Ph.sub.2P(CH.sub.2).sub.2NH.sub.2).sub.2] (2) can also function as a catalyst precursor for this transformation. In the presence of molecular hydrogen in THF, these catalysts (5) and (2) can pick up hydrogen to generate the active transition metal catalyst. One example of an active transition metal catalyst resulting from these catalysts picking up hydride is [Ru(H).sub.2(Ph.sub.2PCH.sub.2CH.sub.2NH.sub.2).sub.2].

(67) In another embodiment, there is provided a transition metal catalyst selected from

(68) ##STR00009##
trans-[Ru((R)-BINAP)(H).sub.2((R,R)-dpen)], [Ru(Cl).sub.2(Ph.sub.2P(CH.sub.2).sub.2NH.sub.2).sub.2], [Ru(COD)(Anthracene)]BF.sub.4, cis-[Ru(CH.sub.3CN).sub.2(η.sup.3-C.sub.3H.sub.5)(COD)]BF.sub.4, [Ru(Ph.sub.2PCH.sub.2CH.sub.2NH.sub.2).sub.2(η.sup.3-C.sub.3H.sub.5)]BF.sub.4, trans-[Ru(H).sub.2(Ph.sub.2P(CH.sub.2).sub.2NH.sub.2).sub.2], [Ru(H)(Ph.sub.2P(CH.sub.2).sub.2NH.sub.2)—(Ph.sub.2P(CH.sub.2).sub.2NH)] or an isomer thereof.

(69) While not wishing to be bound by theory, it is hypothesized that tethering the amine and phosphine groups can increase the thermal stability of the catalyst by preventing dissociative loss of the ligand(s) at high temperature. It has been shown that these types of transition metal catalysts having tethered amine and phosphine groups can have activity for the hydrogenation of amides.

(70) The reaction between 2 equivalents of Ph.sub.2P(CH.sub.2).sub.2NH.sub.2 3 and the Ru precursor cis-[Ru(CH.sub.3CN).sub.2(η.sup.3-C.sub.3H.sub.5)(COD)]BF.sub.4 (4) (wherein COD is 1,5-cyclooctadiene) in THF at 60° C. forms isomers of the π-allyl complex (5) in near-quantitative solution yield by displacement of the COD and MeCN ligands (See Scheme 1, below).

(71) ##STR00010##

(72) Catalyst (5) was identified by .sup.1H, .sup.31P, gCOSY, .sup.1H{.sup.31P} COSY, .sup.1H-.sup.31P gHSQC, TROESY and gTOCSY NMR experiments, Mass Spectrometry and Elemental Analysis. (See also FIGS. 2 and 3) (J. A. Wiles, C. J. A. Daley, R. J. Hamilton, C. G. Leong, S. H. Bergens, Organometallics, 2004, 23, 4564; L. Saudan, C. M. Saudan, C. Debieux, P. Wyss, Angew. Chem. Int. Ed. 2007, 46, 7473; L. Saudan, P. Dupau, J. Riedhauser, P. Wyss, PCT Int. Pat. Appl. WO 2006/106484 A1, Oct. 12, 2006; PCT Int. Pat. Appl. WO 2006/106483, Apr. 4, 2006; L. Saudan, C. Saudan, PCT Int. Pat. Appl. WO 2008/065588 A1, Jun. 5, 2008; PCT Int. Pat. Appl. WO 2010/038209 A1, Apr. 8, 2010; L. Saudan, Acc. Chem. Res. 2007, 40, 1309.)

(73) The catalyst [Ru(COD)(Anthracene)]BF.sub.4 has also been shown to generate an active catalyst with similar activity to that of cis-[Ru(CH.sub.3CN).sub.2(η.sup.3-C.sub.3H.sub.5)(COD)]BF.sub.4 in a reaction with tethered amino phosphine.

(74) Ligands

(75) The bidentate diphosphine ligand (P—P) can be, for example, a compound of the Formula (I):
R.sup.1R.sup.2P-Q.sup.1-PR.sup.3R.sup.4  (I)
wherein R.sup.1, R.sup.2, R.sup.3 and R.sup.4 are each independently selected from (C.sub.1-20)-alkyl, (C.sub.3-20)-cycloalkyl and (C.sub.6-18)-aryl, each group being optionally substituted with one or more substituents each independently selected from (C.sub.1-6)-alkyl, fluoro-substituted (C.sub.1-6)-alkyl, halo, (C.sub.1-6)-alkoxy, fluoro-substituted (C.sub.1-6)-alkoxy and (C.sub.6-14)-aryl, or R.sup.1 and R.sup.2 and/or R.sup.3 and R.sup.4 are joined to form, together with the phosphorus atom to which they are attached, a saturated or unsaturated, monocyclic or polycyclic, substituted or unsubstituted ring system containing from 3 to 14 atoms, Q.sup.1 is selected from unsubstituted or substituted (C.sub.1-10)-alkylene and unsubstituted or substituted (C.sub.1-10)-alkenylene where the substituents on Q.sup.1 are each independently selected from one or more of (C.sub.1-6)-alkyl, fluoro-substituted (C.sub.1-6)-alkyl, halo, (C.sub.1-6)-alkoxy, fluoro-substituted (C.sub.1-6)-alkoxy and unsubstituted or substituted (C.sub.6-14)-aryl; and/or adjacent substituents on Q.sup.1 are joined together to form, including the carbon atoms to which they are attached, one or more unsubstituted or substituted 5-20-membered monocyclic, polycyclic, heterocyclic, carbocyclic, saturated, unsaturated or metallocenyl ring systems; where the term substituted with respect to the Q.sup.1 substituents means that one or more of the available hydrogen atoms on the group are replaced with (C.sub.1-6)-alkyl, fluoro-substituted (C.sub.1-6) alkoxy, fluoro-substituted (C.sub.1-6)-alkoxy, halo or (C.sub.6-14)-aryl; and Q.sup.1 is chiral or achiral.

(76) In some examples, R.sup.1, R.sup.2, R.sup.3 and R.sup.4 are independently selected from (C.sub.1-6)-alkyl, (C.sub.3-10)-cycloalkyl and phenyl, each group being optionally substituted with one to three substituents independently selected from (C.sub.1-4)-alkyl, fluoro-substituted (C.sub.1-4)-alkyl, halo, (C.sub.1-4)-alkoxy and fluoro-substituted (C.sub.1-4)-alkoxy; Q.sup.1 is selected from unsubstituted or substituted (C.sub.1-8)-alkylene where the substituents on Q.sup.1 are independently selected from one to three of (C.sub.1-4)-alkyl, fluoro-substituted (C.sub.1-4)-alkyl, halo, (C.sub.1-4)-alkoxy, fluoro-substituted (C.sub.1-4)-alkoxy, unsubstituted and substituted phenyl and substituted and unsubstituted naphthyl, or adjacent substituents are joined together to form, including the carbon atoms to which they are attached, one or more unsubstituted or substituted phenylene, cyclohexylene, naphthylene, pyridylene or ferrocenylene groups; and Q.sup.1 is chiral or achiral.

(77) In some examples R.sup.1, R.sup.2, R.sup.3 and R.sup.4 are all cyclohexyl, phenyl, xylyl or tolyl.

(78) In some examples the compound of the Formula (I) is

(79) ##STR00011##

(80) The bidentate diamino (N—N) ligand can be, for example, a compound of the Formula (II):
R.sup.5R.sup.6N-Q.sup.2-NR.sup.7R.sup.8  (II)
wherein R.sup.5, R.sup.6, R.sup.7 and R.sup.8 are independently selected from H, (C.sub.1-20)-alkyl, (C.sub.3-10)-cycloalkyl and (C.sub.6-18)-aryl, the latter three groups each being optionally substituted with one or more substituents independently selected from (C.sub.1-6)-alkyl, fluoro-substituted (C.sub.1-6)-alkyl, halo, (C.sub.1-6)-alkoxy, fluoro-substituted (C.sub.1-6)-alkoxy and (C.sub.6-14)-aryl, or R.sup.5 and R.sup.6 and/or R.sup.7 and R.sup.8 are joined to form, together with the nitrogen atom to which they are attached, a saturated or unsaturated, monocyclic or polycyclic, substituted or unsubstituted ring system containing from 3 to 14 atoms, or one of R.sup.5 and R.sup.6, and/or one of R.sup.7 and R.sup.8 are joined with a substituent on Q.sup.2 to form, together with the nitrogen atom to which R.sup.5, R.sup.6, R.sup.7 or R.sup.8 is attached, a 4- to 10-membered saturated or unsaturated, monocyclic or bicyclic ring system, where if the nitrogen atom is part of aromatic ring or is bonded to an adjacent atom via a double bond, the other of R.sup.5 or R.sup.6 and R.sup.7 or R.sup.8 is not present, Q.sup.2 is selected from unsubstituted or substituted (C.sub.1-C.sub.10)-alkenylene and unsubstituted or substituted (C.sub.1-C.sub.10)— wherein R.sup.5, R.sup.6, R.sup.7 and R.sup.8 are independently selected from H, (C.sub.1-20)-alkyl, (C.sub.3-10)-cycloalkyl and (C.sub.6-18)-aryl, the latter three groups each being optionally substituted with one or more substituents independently selected from (C.sub.1-6)-alkyl, fluoro-substituted (C.sub.1-6)-alkyl, halo, (C.sub.1-6)-alkoxy, fluoro-substituted (C.sub.1-6)-alkoxy and (C.sub.6-14)-aryl, or R.sup.5 and R.sup.6 and/or R.sup.7 and R.sup.8 are joined to form, together with the nitrogen atom to which they are attached, a saturated or unsaturated, monocyclic or polycyclic, substituted or unsubstituted ring system containing from 3 to 14 atoms, or one of R.sup.5 and R.sup.6, and/or one of R.sup.7 and R.sup.8 are joined with a substituent on Q.sup.2 to form, together with the nitrogen atom to which R.sup.5, R.sup.6, R.sup.7 or R.sup.8 is attached, a 4- to 10-membered saturated or unsaturated, monocyclic or bicyclic ring system, where if the nitrogen atom is part of aromatic ring or is bonded to an adjacent atom via a double bond, the other of R.sup.5 or R.sup.6 and R.sup.7 or R.sup.8 is not present, Q.sup.2 is selected from unsubstituted or substituted (C.sub.1-C.sub.10)-alkenylene and unsubstituted or substituted (C.sub.1-C.sub.10)-alkenylene where the substituents on Q.sup.2 are independently selected from one or more of (C.sub.1-6)-alkyl, fluoro-substituted (C.sub.1-6)-alkyl, halo, (C.sub.1-6)-alkoxy, fluoro-substituted (C.sub.1-6)-alkoxy and unsubstituted or substituted phenyl; and/or adjacent substituents on Q.sup.2 are joined together to form, including the carbon atoms to which they are attached, one or more unsubstituted or substituted 5-20-membered monocyclic, polycyclic, heterocyclic, carbocyclic, saturated, unsaturated or metallocenyl ring systems; the term substituted with respect to the Q.sup.2 substituents means that one or more of the available hydrogen atoms on the group are replaced with (C.sub.1-6)-alkyl, fluoro-substituted (C.sub.1-6)-alkyl, (C.sub.1-6)-alkoxy, fluoro-substituted (C.sub.1-6)-alkoxy, halo or (C.sub.6-14)-aryl; and Q.sup.2 is chiral or achiral.

(81) In some examples, R.sup.5, R.sup.6, R.sup.7 and R.sup.8 are independently selected from H, (C.sub.1-6)-alkyl, (C.sub.3-10)-cycloalkyl and phenyl, the latter three groups each being optionally substituted with one to three substituents independently selected from (C.sub.1-4)-alkyl, fluoro substituted (C.sub.1-4)-alkyl, halo, (C.sub.1-4)-alkoxy and fluoro-substituted (C.sub.1-4)-alkoxy; and Q.sup.1 is selected from unsubstituted or substituted (C.sub.1-C.sub.8)-alkylene where the substituents on Q.sup.1 are independently selected from one to three of (C.sub.1-4)-alkyl, fluoro-substituted (C.sub.1-4)-alkyl, halo, (C.sub.1-4)-alkoxy, fluoro-substituted (C.sub.1-4)-alkoxy, unsubstituted and substituted phenyl and substituted and unsubstituted naphthyl, or adjacent substituents are joined together to form, including the carbon atoms to which they are attached, one or more unsubstituted or substituted phenylene, cyclohexylene, naphthylene, pyridylene or ferrocenylene groups; and Q.sup.1 is chiral or achiral.

(82) In some examples R.sup.5, R.sup.6, R.sup.7 and R.sup.8 are all H or (C.sub.1-6)-alkyl. In some examples, the optional substituents on Q.sup.2 are selected from (C.sub.1-4)-alkyl and substituted or unsubstituted phenyl. In some examples, the optional substituents on Q.sup.2 are selected from iso-propyl, phenyl and 4-methoxyphenyl.

(83) In some examples, the compound of Formula (II) is

(84) ##STR00012##

(85) The bidentate aminophosphine (P—N) ligand can be, for example, a compound of the Formula (III)
R.sup.9R.sup.10P-Q.sup.3-NR.sup.11R.sup.12  (III)
wherein R.sup.9 and R.sup.10 are independently as previously defined for R.sup.1 to R.sup.4; R.sup.11 and R.sup.12 are independently as previously defined for R.sup.5 to R.sup.8; and Q.sup.3 is as previously defined for Q.sup.1.

(86) The tridentate diaminophosphine (P—N—N) ligand can be, for example, a compound of the Formula (IV):
R.sup.13R.sup.14-Q.sup.4-NR.sup.15-Q.sup.5-NR.sup.16R.sup.17  (IV)
wherein R.sup.13 and R.sup.14 are independently as previously defined for R.sup.1 to R.sup.4, Q.sup.4 and Q.sup.5 are as previously defined for Q.sup.1, R.sup.15 is selected from H, (C.sub.1-20)-alkyl, (C.sub.3-20)-cycloalkyl and (C.sub.6-18)-aryl, the latter three groups each being optionally substituted with one or more substituents independently selected from (C.sub.1-6)-alkyl, fluoro-substituted (C.sub.1-6)-alkyl halo, (C.sub.1-6)-alkoxy, fluoro-substituted (C.sub.1-6)-alkoxy and (C.sub.6-14)-aryl, or R.sup.15 is joined with a substituent on Q.sup.4 and/or Q.sup.5 to form, together with the nitrogen atom to which R.sup.15 is attached, a 4- to 10-membered saturated or unsaturated, monocyclic or bicyclic ring system, and R.sup.16 and R.sup.17 are independently as previously defined for R.sup.5-R.sup.8.

(87) The tridentate diaminophosphine (P—N—P) ligand can be, for example, a compound of the Formula (V):
R.sup.18R.sup.19P-Q.sup.6-NR.sup.20-Q.sup.7-PR.sup.21R.sup.22  (V)
wherein R.sup.18, R.sup.19, R.sup.21 and R.sup.22 are independently as previously defined for R.sup.1 to R.sup.4, Q.sup.6 and Q.sup.7 are as previously defined for Q.sup.1, and R.sup.20 is as previously defined for R.sup.15.

(88) The tetradentate diaminodiphosphine (P—N—N—P) ligand can be, for example, a compound of the Formula (VIa) or (VIb):
R.sup.23R.sup.24P-Q.sup.8-NR.sup.25-Q.sup.9-NR.sup.26-Q10-PR.sup.27R.sup.28  (VIb)
R.sup.23R.sup.24P-Q.sup.8=N-Q.sup.9-N=Q.sup.10-PR.sup.27R.sup.28  (VIb)
wherein R.sup.23, R.sup.24, R.sup.27 and R.sup.28 are independently as previously defined for R.sup.1 to R.sup.4, Q.sup.8, Q.sup.9 and Q.sup.10 are independently as previously defined for Q.sup.1, and R.sup.25 and R.sup.26 are independently as previously defined for R.sup.15.

(89) The monodentate phosphine (P) ligand can be, for example, a compound of the Formula (VII):
PR.sup.29R.sup.30R.sup.31  (VII)
wherein R.sup.29, R.sup.30 and R.sup.31 are independently selected from (C.sub.6-18)-aryl, (C.sub.1-20)-alkyl and (C.sub.3-20)-cycloalkyl, each being optionally substituted with one or more substituents independently selected from (C.sub.1-6)-alkyl, fluoro-substituted (C.sub.1-6)-alkyl, halo, (C.sub.1-6)-alkoxy, fluoro-substituted (C.sub.1-6)-alkoxy and (C.sub.6-14)-aryl, or R.sup.29 and R.sup.30 or R.sup.29 and R.sup.31 or R.sup.30 and R.sup.31 or R.sup.29, R.sup.30 and R.sup.31 are joined to form, together with the phosphorous atom to which they are attached, a saturated or unsaturated, monocyclic or polycyclic, substituted or unsubstituted ring system containing from 3 to 14 atoms.

(90) In some examples, R.sup.29, R.sup.30 and R.sup.31 are independently selected from phenyl, (C.sub.1-6)-alkyl and (C.sub.3-10)-cycloalkyl, each being optionally substituted with one to three substituents independently selected from (C.sub.1-4)-alkyl, fluoro-substituted (C.sub.1-4)-alkyl, halo, (C.sub.1-4)-alkoxy and fluoro-substituted (C.sub.1-6)-alkoxy.

(91) In some examples, R.sup.29, R.sup.30 and R.sup.31 are all cyclohexyl, phenyl, xylyl or tolyl.

(92) The monodentate amino (N) ligand can be, for example, a compound of the formula (VIII):
NR.sup.32R.sup.33R.sup.34  (VIII)
wherein R.sup.32, R.sup.33 and R.sup.34 are independently selected from H, (C.sub.1-20)-alkyl, (C.sub.3-20)-cycloalkyl and (C.sub.6-18)-aryl, the latter three groups each being optionally substituted with one or more substituents independently selected from (C.sub.1-6)-alkyl, fluoro-substituted (C.sub.1-6)-alkyl, halo, (C.sub.1-6)-alkoxy, fluoro-substituted (C.sub.1-6)-alkoxy and (C.sub.6-14)-aryl, or R.sup.32 and R.sup.33 or R.sup.32 and R.sup.34 or R.sup.33 and R.sup.34 or R.sup.32, R.sup.33 and R.sup.34 are joined to form, together with the nitrogen atom to which they are attached, a saturated or unsaturated, monocyclic or polycyclic, substituted or unsubstituted ring system containing from 3 to 14 atoms.

(93) In some examples, R.sup.32, R.sup.33 and R.sup.34 are independently selected from H, (C.sub.1-6)-alkyl, (C.sub.3-10)-cycloalkyl and phenyl, the latter three groups each being optionally substituted with one to three substituents independently selected from (C.sub.1-4)-alkyl, fluoro-substituted (C.sub.1-4)-alkyl, halo, (C.sub.1-4)-alkoxy and fluoro-substituted (C.sub.1-4)-alkoxy.

(94) Some suitable ligands for the transition metal catalyst include, but are not limited to:

(95) ##STR00013## ##STR00014##
wherein R is alkyl and/or aryl and/or H, R.sup.1 is alkyl and/or aryl, R.sup.2 is alkyl and/or aryl and/or H, and rings can be either alkyl or aryl, and x>1.

(96) In certain specific examples, ligands can include:

(97) ##STR00015##

(98) In some examples, the neutral monodentate ligand is water, acetonitrile, DMF, ammonia, pyridine, tetrahydrofuran (THF), CO, t-BuCN or t-BuNC.

(99) In some examples, the anionic monodentate ligand is halo, (C.sub.1-6)-alkoxy, hydroxy, thiocyanate, cyano, carboxylate, sulfonates or nitrates. In some specific examples, halo is chloro.

(100) Substrates

(101) In some examples, the substrate comprising one or more amide moieties is a compound of the Formula (IX):

(102) ##STR00016##
wherein R.sup.35 and R.sup.36 are independently selected from (C.sub.1-20)-alkyl, (C.sub.3-20)-cycloalkyl and (C.sub.6-18)-aryl, each group being optionally substituted, wherein the optional substituents are independently selected from one or more of (C.sub.1-6)-alkyl, fluoro-substituted (C.sub.1-6)-alkyl, halo, (C.sub.1-6)-alkoxy, fluoro-substituted (C.sub.1-6)-alkoxy and (C.sub.6-14)-aryl and/or one or more of the carbon atoms is optionally replaced with a heteromoiety selected from O, S, N, NH and N—(C.sub.1-6)-alkyl, or R.sup.35 and R.sup.36 are joined together to form, including the carbon atoms to which they are attached and the amide nitrogen, an unsubstituted or substituted 5-20-membered monocyclic, polycyclic, heterocyclic, carbocyclic, saturated or unsaturated ring system, wherein the optional substituents are selected from one or more of (C.sub.1-6)-alkyl, fluoro-substituted (C.sub.1-6)-alkyl, halo, (C.sub.1-6)-alkoxy, fluoro-substituted (C.sub.1-6)-alkoxy and (C.sub.6-14)-aryl; and R.sup.37 is selected from H, (C.sub.1-6)-alkyl, (C.sub.3-8)-cycloalkyl and (C.sub.6-14)-aryl, the latter three groups being optionally substituted with one or more of (C.sub.1-6)-alkyl, fluoro-substituted (C.sub.1-6)-alkyl, halo, (C.sub.1-6)-alkoxy, fluoro-substituted (C.sub.1-6)-alkoxy and (C.sub.6-14)-aryl and/or one or more of the carbon atoms is optionally replaced with a heteromoiety selected from O, S, N, NH and N—(C.sub.1-6)-alkyl; and where the compound of Formula (IX) is chiral or achiral.

(103) In some examples, R.sup.37 is H, (C.sub.1-3)-alkyl, (C.sub.3-6)-cycloalkyl or phenyl, the latter three groups each being optionally substituted, wherein the optional substituents are independently selected from (C.sub.1-6)-alkyl, fluoro-substituted (C.sub.1-6)-alkyl, halo, (C.sub.1-6)-alkoxy, fluoro-substituted (C.sub.1-6)-alkoxy and phenyl.

(104) In some examples, R.sup.35 and R.sup.36 are joined together to form, including the carbon atoms to which they are attached and the amide carbon, a polycyclic (C.sub.8-12)-cycloalkyl or (C.sub.8-12)-cycloalkenyl ring system, each being optionally substituted with one to five substituents independently selected from (C.sub.1-6)-alkyl, fluoro-substituted (C.sub.1-6)-alkyl, halo, (C.sub.1-6)-alkoxy, fluoro-substituted (C.sub.1-6)-alkoxy and (C.sub.6)-aryl, and in which one to five carbon atoms in the polycyclic (C.sub.8-12)-cycloalkyl or (C.sub.8-12)-cycloalkenyl ring system are optionally replaced with a heteromoiety selected from O, N, NH, N—(C.sub.1-6)-alkyl and S.

(105) In some examples, R.sup.35 and R.sup.36 are joined to form, including the carbon atoms to which they are attached and the imide nitrogen, a ring system selected from:

(106) ##STR00017##

(107) The compound of formula (IX) can also be, for example, mono-reduced to a compound of the Formula (Xa) or (Xb)

(108) ##STR00018##

(109) In certain examples, suitable substrates include the following, wherein R.sup.1 to R.sup.4 may be components of a ring, shown below.

(110) ##STR00019##

(111) In one example, the substrate can be a cyclic carbamate, a specific example of this reaction performed with [Ru(Cl).sub.2(Cy.sub.2PCH.sub.2CH.sub.2NH.sub.2).sub.2] (Cy=cyclohexyl) as the transition metal catalyst. which is shown below:

(112) ##STR00020##

(113) Process

(114) Described herein is a process for hydrogenating a wide variety of cyclic and acyclic amides, and analogues thereof, to the corresponding alcohol and amine products using a transition metal catalyst. The present reaction can be carried out under mild conditions, such as with low catalyst loading, low hydrogen pressure, and low temperature to effect the transformation, compared with other known amide bond reductions. The present reactions can also be selective for amide bond cleavage, and can be carried out in base free conditions.

(115) The present catalysts and methods are also capable of carrying out hydrogenation reactions on other amide derivatives, and carboxylic acid derivatives including but not limited to carboxamide, and carbonic acid derivatives including but not limited to carbonates, carbamates and ureas.

(116) Processes of the present invention may be conveniently practiced in the form of a kit. Such a kit preferably contains the appropriate compounds and/or compositions, and instructions for the use thereof.

(117) Selection of the appropriate solvent for the present catalytic process will be dependent on a number of factors including, for example, solubility of substrate, reactants and/or product(s), cost, availability, and temperature and pressure of the reaction. The selection of a specific solvent will be well within the abilities of a person of ordinary skill in the art. In some examples, the process is performed in a solvent selected from tetrahydrofuran (THF), diethyl ether, chlorinated solvents, toluene and mixtures thereof.

(118) As noted above, the present process is optionally performed in the presence of a base. In some examples, the base is an organic non-coordinating base, a carbonate salt, a carboxylate salt, an alcoholate salt, a hydroxide salt or a silazine salt. In some specific examples, the base can be, for example, tBuOK or [(CH.sub.3).sub.3Si].sub.2NK. In alternative examples, the present process is performed in the absence of a base.

(119) The present process is performed in the presence of a hydrogen source, specifically H.sub.2. In some examples, the hydrogen gas is used at a pressure in the range of about 1 atm to about 100 atm. In some examples, the hydrogen gas is used at a pressure in the range of about 40 atm to about 60 atm. In some examples, the hydrogen gas is used at a pressure of 50 atm or less. In some examples, the hydrogen gas is used at a pressure of 10 atm or less. In other specific examples, the hydrogen gas is used at a pressure of between about 1 atm to about 10 atm.

(120) In some examples, the process is performed at a temperature of about −50° C. to about 150° C.

(121) To gain a better understanding of the invention described herein, the following examples are set forth. It should be understood that these examples are for illustrative purposes only. Therefore, they should not limit the scope of this invention in any way.

EXAMPLES

Example 1

Synthesis of Substrates

Preparation of N-Methylsulfonylpyrrolidin-2-one (2a)

(122) ##STR00021##

(123) N-Methylsulfonylpyrrolidin-2-one (2a) was prepared according to a procedure reported by Ikariya and co-workers. (M. Ito, L. W. Koo, A. Himizu, C. Kobayashi, A. Sakaguchi, T. Ikariya, Angew. Chem. Int. Ed. 2009, 48, 1324.) A solution of nBuLi (2.5 M, 11.8 mL, 29.4 mmol) in n-hexane was added drop-wise over 30 min to a stirred solution of 2-pyrrolidinone (24.5 mmol) in 50 mL of anhydrous THF at −78° C. under Argon. The resulting white slurry was then stirred for an additional 30 min before being quenched with freshly distilled methansulfonylchloride (24.5 mmol). The reaction mixture was then allowed to warm gradually to RT. The mixture that resulted was then washed with a saturated solution of NH.sub.4Cl after which it was extracted three times with AcOEt. The combined AcOEt layers were then washed with brine and dried over anhydrous MgSO.sub.4 before being concentrated under reduced pressure. The product was purified by column chromatography using 3:1 Hexanes:AcOEt. Yield: 50%.

Preparation of N-Acetylpyrrolidin-2-one (2b)

(124) ##STR00022##

(125) N-Acetylpyrrolidin-2-one (2b) was prepared according to a procedure described by MacKenzie and co-workers. (J. Seyden-Penne, Reductions by the Alumino and Borohydrides in Organic Synthesis, 2nd Ed., Wiley-VCH, New York, 1997. G. W. Gribble, Chem. Soc. Rev. 1998, 27, 395.) A mixture of 2-pyrrolidinone (39.3 mmol) and acetic anhydride (78.7 mmol) was added to a 3-neck flask equipped with a magnetic stir bar. The contents of the flask were then heated at reflux for 2 h under Argon. The pale yellow mixture that resulted was then allowed to cool to RT before being concentrated in vacuo. The crude product was then purified by distillation. Yield: 96%

Preparation of N-Phenylpyrrolidin-2-one (2c) and N-Phenylpiperidone (6)

(126) ##STR00023##

(127) N-Phenylpyrrolidin-2-one (2c) and N-Phenylpiperidone (6) were prepared by a modification to the procedure reported by Ukita and co-workers. (G. Pelletier, W. S. Bechara, A. B. Charette, J. Am. Chem. Soc. 2010, 132, 12817; S. Das, D. Addis, S. Zhou, K. Junge, M. Beller, J. Am. Chem. Soc. 2010, 132, 1770; Y. Sunada, H. Kawakami, T. Imaoka, Y. Matoyama, H. Nagashima. Angew. Chem. Int. Ed. 2009, 48, 9511.) A mixture of iodobenzene (24.8 mmol), lactam (12.4 mmol), anhydrous K.sub.2CO.sub.3 (12.4 mmol) and CuI in anhydrous DMF was refluxed at 150° C. overnight under an Argon atmosphere. The reaction mixture was then allowed to cool to RT before adding a minimal amount of a 2.5% aqueous NH.sub.4OH solution. The resulting blue solution was then extracted twice with AcOEt and the combined AcOEt layers were washed with brine before being collected and dried over anhydrous MgSO.sub.4. The organic layer was then concentrated in vacuo. The product was then purified by column chromatography using 2:1 Hexanes: AcOEt. Yields were 50% and 40% respectively.

Preparation of N,N-Diphenylbenzamide (8a)

(128) ##STR00024##

(129) N,N-Diphenylbenzamide (8a) was prepared by a modification to the procedure reported by Charette and co-workers. (B. Wojcik, H. Adkins, J. Am. Chem. Soc. 1934, 56, 2419; b) R. M. King, U.S. Pat. No. 4,448,998, May 15, 1984.) Benzoyl chloride (4.39 mmol) was added drop-wise to a rapidly stirred solution of diphenylamine (3.66 mmol) and pyridine (18.29 mmol) in 40.0 mL of anhydrous CH.sub.2Cl.sub.2 at RT. The reaction mixture was then stirred overnight under Argon. TLC was used to monitor the reaction. Upon completion, the reaction was diluted with AcOEt and transferred to a separation funnel. The organic layer was then washed with an equal volume of 1N HCl. The organic layer was collected, washed with an equivalent volume of brine and dried over MgSO.sub.4 before being concentrated under reduced pressure. The product was purified by trituration in warm hexanes and isolated by gravity filtration. Yield was 60%.

Preparation of N-Methyl-N-Phenylbenzamide (8b) and 1-Benzoylpiperidine (8d)

(130) ##STR00025##

(131) N-Methyl-N-Phenylbenzamide (8b) and 1-Benzoylpiperidine (8d) were prepared by a modification to the procedure reported by Charette and co-workers. (B. Wojcik, H. Adkins, J. Am. Chem. Soc. 1934, 56, 2419; R. M. King, U.S. Pat. No. 4,448,998, May 15, 1984.) Benzoyl chloride (52.8 mmol) was added drop-wise to a rapidly stirred solution of the amine (58.1 mmol) and triethylamine (66.1 mmol) in 40.0 mL of anhydrous CH.sub.2Cl.sub.2 at 0° C. The reaction mixture was then allowed to warm up to RT and stirred over overnight under Argon. The mixture was then diluted with an equivalent volume of CH.sub.2Cl.sub.2 (40.0 mL) before being transferred to a separation funnel. The combined CH.sub.2Cl.sub.2 layers were then washed with 40.0 mL of an aqueous 1N HCl. The organic layer was collected, washed with an equivalent volume of brine and dried over anhydrous MgSO.sub.4 before being concentrated under reduced pressure. The product was then purified by distillation. Yields were 90% and 80% respectively.

Preparation of Acetanilide (8j)

(132) ##STR00026##

(133) Acetanilide (8j) was prepared according to a procedure described by Fagnou and co-workers. (C. Hirosawa, N. Wakasa, T. Fuchikami, Tetrahedron Lett. 1996, 37, 6749.) The acid anhydride (88.7 mmol) was added drop wise to a rapidly stirred solution of aniline (73.9 mmol) in 200 mL of anhydrous CH.sub.2Cl.sub.2 under Argon at RT. Thin Layer Chromatography (TLC) was then used to monitor the progress of the reaction. Upon completion, the reaction was then quenched with a saturated aqueous solution of Na.sub.2CO.sub.3. The organic layer was then collected, washed with brine and dried over anhydrous MgSO.sub.4 before being concentrated under reduced pressure. The product was the purified by recrystallization in hot water. Yield: 90%.

(134) Spectroscopic Identification of Substrates

(135) N-Methylsulfonylpyrrolidin-2-one (2a): Crystalline colorless solid: .sup.1H NMR (499.815 MHz, CDCl.sub.3, 27° C.): δ 2.14 (2H, p, J=7.7 Hz, CH.sub.2), δ 2.57 (2H, t, J=8 Hz, CH.sub.2), δ 3.25 (3H, s, CH.sub.3), δ 3.86 (2H, J=7 Hz, CH.sub.2). (M. Ito, L. W. Koo, A. Himizu, C. Kobayashi, A. Sakaguchi, T. Ikariya, Angew. Chem. Int. Ed. 2009, 48, 1324.)

(136) N-Acetylpyrrolidin-2-one (2b): Colorless oil: .sup.1H NMR (499.815 MHz, CDCl.sub.3, 27° C.): δ 2.01 (2H, p, J=9 Hz, CH.sub.2), δ 2.48 (3H, s, CH.sub.3), δ 2.58 (2H, t, J=12 Hz, CH.sub.2), δ 3.78 (2H, t, J=11.5 Hz, CH.sub.2). (M. W. Irvine, G. L. Patrick, J. Kewney, S. F. Hastings, S. J. Mackenzie, Bioorg. Med. Chem. Lett. 2008, 18, 2032.)

(137) N-Phenylpyrrolidin-2-one (2c): White powder: .sup.1H NMR (499.815 MHz, CDCl.sub.3, 27° C.): δ 2.15 (2H, p, J=7.2 Hz, CH.sub.2), δ 2.60 (2H, t, J=8 Hz, CH.sub.2), δ 3.86 (2H, t, J=7 Hz, CH.sub.2), δ 7.13 (1H, t, J=7.5 Hz, aromatic CH), δ 7.36 (2H, t, J=7.5 Hz, aromatic 2 CH), δ 7.60 (2H, d, J=8 Hz, aromatic 2 CH). (M. Sugahara, T. Ukita, Chem. Pharm. Bull. 1997, 45, 719.)

(138) N-Methylpyrrolidin-2-one (2d): Colorless oil: .sup.1H NMR (498.122 MHz, CDCl.sub.3, 27° C.): δ 2.00 (2H, p, J=7 Hz, CH.sub.2), δ 2.35 (2H, t, J=8.2 Hz, CH.sub.2), δ 2.82 (3H, s, CH.sub.3), δ 3.36 (2H, t, J=7 Hz, CH.sub.2).

(139) 2-Pyrrolidinone (2e): Colorless viscous oil: (499.815 MHz, CDCl.sub.3, 27° C.): δ 2.05 (2H, p, J=7.7 Hz, CH.sub.2), δ 2.23 (2H, t, J=8 Hz, CH.sub.2), δ 3.35 (211, t, J=7 Hz, CH.sub.2), δ 7.10 (1H, brs, NH).

(140) N-Phenylpiperidinone (6): White powder: .sup.1H NMR (498.122 MHz, CDCl.sub.3, 27° C.): δ 1.93 (4H, m, 2 CH.sub.2), δ 2.55 (2H, t, J=6 Hz, CH.sub.2), δ 3.63 (2H, t, J=6 Hz, CH.sub.2), δ 7.24 (3H, m, aromatic 3 CH), δ 7.38 (2H, m, aromatic 2 CH). (M. Sugahara, T. Ukita, Chem. Pharm. Bull. 1997, 45, 719.)

(141) ε-Caprolactam (7): Colorless crystals: .sup.1H NMR (498.122 MHz, CDCl.sub.3, 27° C.): δ 1.62-1.76 (6H, m, 3 CH.sub.2), δ 2.46 (2H, m, CH.sub.2), δ 3.20 (2H, m, CH.sub.2), δ 5.90 (1H, brs, NH).

(142) N,N-Diphenylbenzamide (8a): White powder: (498.124 MHz, CDCl.sub.3, 27° C.): δ 7.13-7.21 (8H, m, aromatic 8 CH), δ 7.24-7.29 (511, m, aromatic 5 CH), δ 7.43 (2H, d, J=7.5 Hz, aromatic 2 CH). (G. Barbe, A. B. Charette, J. Am. Chem. Soc. 2008, 130, 18.)

(143) N-Methyl-N-Phenylbenzamide (8b): Straw colored viscous liquid: .sup.1H NMR (498.122 MHz, CDCl.sub.3, 27° C.): δ 3.50 (3H, s, CH.sub.3), δ 7.03 (2H, d, J=8 Hz, aromatic 2 CH), δ 7.15-7.19 (3H, m, aromatic 3 CH), δ 7.19-7.25 (3H, m, aromatic 3 CH), 7.29 (2H, d, J=8 Hz, aromatic 2 CH). (G. Barbe, A. B. Charette, J. Am. Chem. Soc. 2008, 130, 18.)

(144) N,N-Dimethylbenzamide (8c): White powder: .sup.1H NMR (498.122 MHz, CDCl.sub.3, 27° C.): δ 2.97 (3H, brs, CH.sub.3), δ 3.01 (3H, brs, CH.sub.3), δ 7.38-7.40 (5H, m, aromatic 5 CH).

(145) 1-Benzoylpiperidine (8d): Straw colored vicous oil, white solid upon seeding: (499.815 MHz, CDCl.sub.3, 27° C.): δ 1.40-1.70 (6H, m, 3 CH.sub.2), δ 3.29 (2H, brs, CH.sub.2), δ 3.70 (2H, brs, CH.sub.2), δ 7.37 (5H, s, aromatic 5 CH). (G. Barbe, A. B. Charette, J. Am. Chem. Soc. 2008, 130, 18.)

(146) Benzanilide (8e): Off-white powder: (499.815 MHz, CDCl.sub.3, 27° C.): δ 7.16 (1H, t, J=7.2 Hz, aromatic CH), δ 7.38 (2H, t, J=7.8 Hz, aromatic 2 CH), δ 7.49 (2H, t, J=7.5 Hz, aromatic 2 CH), δ 7.55 (1H, t, J=7.5 Hz, aromatic CH), δ 7.64 (2H, d, J=8.2 Hz, aromatic 2 CH), 7.82 (1H, brs, NH), δ 7.86 (2H, d, J=7 Hz, aromatic 2 CH).

(147) N-Methylbenzamide (80: White crystals: .sup.1H NMR (498.124 MHz, CDCl.sub.3, 27° C.): δ 3.01 (3H, d, J=5 Hz, CH.sub.3), δ 6.17 (1H, brs, NH), δ 7.42 (2H, t, J=7.5 Hz, aromatic 2 CH), δ 7.48 (1H, t, J=7.5 Hz, aromatic CH), δ 7.76 (2H, d, J=8.2 Hz, aromatic 2 CH).

(148) N,N-Diphenylacetamide (8g): White powder: (499.815 MHz, CDCl.sub.3, 27° C.): δ 2.09 (3H, s, CH.sub.3), δ 7.29 (4H, d, J=8 Hz, aromatic 4CH), δ 7.10-7.50 (6H, m, aromatic 6CH).

(149) N-Methylacetanilide (8h): Colorless crystals: .sup.1H NMR (498.122 MHz, CDCl.sub.3, 27° C.): δ 1.86 (3H, s, CH.sub.3), δ 3.26 (3H, s, CH.sub.3), δ 7.18 (2H, d, J=7.8 Hz, aromatic 2 CH), δ 7.33 (1H, t, J=7.5 Hz, aromatic CH), δ 7.42 (2H, t, J=7.2 Hz, aromatic 2 CH).

(150) N,N-Dimethylacetamide (8i): Colorless liquid: .sup.1H NMR (498.122 MHz, CDCl.sub.3, 27° C.): δ 2.05 (3H, s, CH.sub.3), δ 2.91 (3H, s, CH.sub.3), δ 2.98 (3H, s, CH.sub.3).

(151) Acetanilide (8j): Colorless crystals: .sup.1H NMR (499.815 MHz, CDCl.sub.3, 27° C.): δ 2.18 (3H, s, CH.sub.3), δ 7.10 (1H, t, J=7.5 Hz, aromatic CH), δ 7.15 (1H, brs, NH), δ 7.32 (2H, t, J=8 Hz, aromatic 2 CH), δ 7.49 (2H, d, J=7.5 Hz, aromatic 2 CH). (D. R. Stuart, M. Bertrand-Laperle, K. M. N. Burgess, K. Fagnou, J. Am. Chem. Soc. 2008, 130, 16474)

Example 2

Synthesis of Ruthenium Catalysts

Preparation of Catalyst [Ru(Ph2PCH2CH2NH2)2(η3-C3H5)]BF4 (5)

(152) In a glove box, 0.75 mmol of cis-[Ru(CH.sub.3CN).sub.2(η.sup.3-C.sub.3H.sub.5)(COD)]BF.sub.4 (4), ((COD is 1,5-cyclooctadiene), was added to a schlenk flask equipped with a stir bar. The flask was then attached to a schlenk line and 4.0 mL of freshly distilled THF added. The mixture was then rapidly stirred and a 1.0 mL THF solution of Ph.sub.2PCH.sub.2CH.sub.2NH.sub.2, 3 (1.5 mmol, 2 equiv) in an NMR tube was added with the aid of a cannula. Any residue in the NMR tube and cannula was washed into the flask with 7.0 mL of THF. The contents of the flask were then heated at 60° C. for 1.5 h to form a golden-brown solution. The solution was allowed to cool to RT before the solvent was removed by evaporation. The crude mixture was then dissolved in 2.0 mL of freshly distilled CH.sub.2Cl.sub.2 and the product, (5) was precipitated from the solution using copious amounts of freshly distilled Et.sub.2O. The light yellow solid that resulted was isolated via filtration under Argon and washed three times with 5.0 mL aliquots of Et.sub.2O. The solid was then dried in vacuo. Yield: 51%. NMR spectra of the filtrate (after the solvent was removed under vacuum) showed it contained (5) as the sole Ru-containing species. (See FIGS. 2 and 3).

(153) In Situ Preparation of the Catalyst (5) with [(CH.sub.3).sub.3Si].sub.2NK

(154) The preparation of catalyst precursor (4) was previously described by Bergens et al. (J. A. Wiles, C. J. A. Daley, R. J. Hamilton, C. G. Leong, S. H. Bergens, Organometallics. 2004, 23, 4564.)

(155) A mixture of cis-[Ru(CH.sub.3CN).sub.2(η.sup.3-C.sub.3H.sub.5)(COD)]BF.sub.4 (4), (0.005 mmol) and 2 equiv of Ph.sub.2PCH.sub.2CH.sub.2NH.sub.2, (0.010 mmol) in freshly distilled anhydrous THF (0.5 mL) under Argon was heated in an NMR tube using water bath at 60° C. with periodic shaking for 30 min. The resulting solution was cooled for 1 min to 0° C. using an ice bath before cooling to −78° C. using a dry ice/acetone bath. H.sub.2 (˜2 atm) was cannulated into the NMR tube at −78° C. The tube was then shaken for 10 sec, and promptly returned to the bath. This shaking process was repeated nine times. 40/50 equiv. (0.20-0.25 mmol) of [(CH.sub.3).sub.3Si].sub.2NK in THF (0.5 mL) was subsequently added via cannula under H.sub.2 (˜2 atm). The shaking process was carried out an additional ten times. The solution color changed from light yellow to orange during this addition.

Preparation of [RuCl2(Ph2PCH2CH2NH2)2] (2)

(156) The preparation of catalyst (2) was previously described by Saudan et al. (L. Saudan, P. Dupau, J-J. Riedhauser, P. Wyss, U.S. Pat. No. 7,763,758 B2. Sep. 12, 2007.)

(157) In a glove box, [RuCl.sub.2(PPh.sub.3).sub.3] (0.25 mmol) was added to a schlenk flask equipped with a magnetic stir bar. The flask was then attached to a schlenk line and 3.4 mL of freshly distilled toluene added. The mixture was then rapidly stirred. A 1.7 mL toluene solution of Ph.sub.2PCH.sub.2CH.sub.2NH.sub.2, (0.50 mmol) in an NMR tube was then added via a cannula. Any residue in the NMR tube and cannula was washed into the flask with 1.7 mL of toluene. The light yellow mixture was then heated at 100° C. for 6 h. The yellow suspension that resulted was allowed to cool to RT before collecting the precipitate by filtration under Argon. The precipitate was then washed with 10.0 mL portions of toluene, three times (until colorless). The yellow solid was then dried in vacuo. Yield: 90%. Note: Excessive scraping of the product should be minimised to prevent the build-up of static electricity.

(158) Characterization of [RuCl.sub.2(Ph.sub.2PCH.sub.2CH.sub.2NH.sub.2).sub.2] (2)

(159) The identity of compound (2) was confirmed using information reported in the literature. (M. Kilner, D. V. Tyers, S. P. Crabtree, M. A. Wood, PCT Int. Pat. Appl. WO 03/093208 A1, Nov. 13, 2003; A. A. N. Magro, G. R. Eastham, D. Cole-Hamilton, Chem. Commun. 2007, 3154; US Pat. 2010/0010261 A1, Jan. 14, 2010.) .sup.31P {.sup.1H} NMR −(161.839 MHz, freshly distilled CD.sub.2Cl.sub.2, 27° C.): 55.4 ppm (trans, d, 2 J.sub.P-P=32 Hz), 61.8 ppm (cis, s), 66.8 ppm (trans, d, 2J.sub.P-P=32 Hz). Ratio cis:trans is 52:48. HRMS (ESI*+) m/z calculated for C.sub.28H.sub.32Cl.sub.2N.sub.2P.sub.2[.sup.102Ru] (M*+): 630.0456. Found: 630.0455. Difference (ppm): −0.12 ppm. Elemental analysis calculated for C.sub.28H.sub.32Cl.sub.2N.sub.2P.sub.2Ru: N, 4.44; C, 53.34; H, 5.12. Found: N, 4.55; C, 53.50; H, 4.94.

(160) Characterization of [Ru(η.sup.3-C.sub.3H.sub.5)(Ph.sub.2PCH.sub.2CH.sub.2NH.sub.2).sub.2]BF.sub.4 (5)

(161) ##STR00027##

(162) FIG. 2 shows the .sup.31P {.sup.1H} NMR Spectrum of the mixture of (5)-major and (5)-minor. 201.643 MHz, freshly distilled CD.sub.2Cl.sub.2, 27° C.: 48.5 ppm (minor, s), 51.9 ppm (major, d, 2J.sub.P-P=29.6 Hz), 69.9 ppm (major, d, 2J.sub.P-P=30.2 Hz). Ratio major:minor is 91:9 (best sample). HRMS (ESI+) m/z calculated for C.sub.31H.sub.37N.sub.2P.sub.2[.sup.102Ru] (M+): 601.147. Found: 601.1476. Difference (ppm): 0.98 ppm. Elemental analysis calculated for C.sub.31H.sub.37N.sub.2P.sub.2BF.sub.4Ru: N, 4.07; C, 54.16; H, 5.42. Found: N, 3.81; C, 54.24; H, 5.61.

(163) FIG. 3 shows the .sup.1H{.sup.31P} and .sup.31P NMR spectra of [Ru(η.sup.3-C.sub.3H.sub.5)(Ph.sub.2PCH.sub.2CH.sub.2NH.sub.2).sub.2]BF.sub.4 recorded on a Varian Inova four-channel 500 MHz spectrometer at −60° C. in CD.sub.2Cl.sub.2. Peaks were assigned using .sup.1H, .sup.31P, gCOSY, .sup.1H{.sup.31P}gCOSY, .sup.1H-.sup.31P gHSQC, TROESY and gTOCSY NMR experiments. Legend: Major Isomer (*); Minor isomer (.square-solid.); Residual Solvent (φ); Major Allyl (a*); Minor Allyl (a); Major 2-(diphenyl-phosphino)ethylamine ligand (NH=1**, CH=1*); Minor 2-(diphenylphosphino)-ethylamine ligand (l′, l); Major Ortho-Aromatic CH (δ*); Minor Ortho-Aromatic CH (δ)

(164) Preliminary .sup.31P{.sup.1H} and Hydride Region .sup.1H NMR Study on the Reactivity of (5) Towards H.sub.2 and Base in THF-d.sub.8

(165) FIG. 4 shows the combined spectra from the NMR study of the reactivity of (5) towards H.sub.2 and base in THF-d.sub.8 undertaken at −80° C. using ˜1 atm Ar (bottom), RT using ˜1 atm H.sub.2 (middle) and RT using ˜4 atm H.sub.2 (top). Legend: Major Isomer of (5) (*); Minor Isomer of (5) (.square-solid.); Peaks assigned to Ruthenium Mono-hydride Species, (.circle-solid.); Peak assigned to Ruthenium Dihydride, trans-[Ru(H).sub.2(Ph.sub.2P(CH.sub.2).sub.2NH.sub.2).sub.2], (✓)

(166) FIG. 5 shows the combined spectra from the study of the reactivity of (5) towards H.sub.2 and base in THF-d.sub.8 undertaken at −80° C. using ˜1 atm Ar (bottom), RT using ˜1 atm H.sub.2 (middle) and RT using ˜4 atm H.sub.2 (top). Legend: Ruthenium Mono-hydride Species, (.circle-solid.); Ruthenium Dihydride, trans-[Ru(H).sub.2(Ph.sub.2P(CH.sub.2).sub.2NH.sub.2).sub.2], (✓)

(167) FIG. 6 shows a comparison of the hydride region between (5) and (11) using ˜1 atm H.sub.2 and KN[(CH.sub.3).sub.3Si].sub.2 as Base in THF-d.sub.8 at RT.

Example 3

Hydrogenation Reactions

(168) General Conditions

(169) All pressure reactions were carried out in a glass (for a maximum of 4 atmospheres {atm} of H.sub.2 (g)) or stainless steel (for 50 atm H.sub.2 (g)) autoclave equipped with a stir bar. Deuterated solvents were obtained from Cambridge Isotope Laboratories and Aldrich. Common solvents were distilled over appropriate drying reagents. (L. F. Armarego, C. L. L. Chai, Purification of Laboratory Chemicals, 6th Edition, Elsevier, Mass., 2009.) THF was distilled over sodium/benzophenone before each experiment. Toluene, and CH.sub.2Cl.sub.2 were distilled over CaH.sub.2. Potassium bis(trimethylsilyl)amide (95%) and Sodium Methoxide (95%) were purchased from Aldrich and 2-(diphenylphosphino)ethylamine (95%) was purchased from Strem. These reagents were used as received. Other common laboratory chemicals and reagents were obtained from Aldrich, Alfa Aesar, TCI America, and Strem, and were used as received unless stated otherwise. Ultra high purity grade hydrogen gas was purchased from Praxair.

(170) .sup.1H, .sup.13C, and .sup.31P NMR spectra were collected using Varian Inova (400 MHz), and Varian DirectDrive (500 MHz) spectrometers. .sup.1H and .sup.13C NMR chemical shifts are reported in parts per million (δ) relative to TMS with the respective solvent as the internal reference. .sup.31P NMR chemical shifts are reported in parts per million (δ) relative to 85% H.sub.3PO.sub.4 as the external reference. NMR peak assignments were made using gCOSY, and .sup.1H-.sup.13C gHSQC NMR experiments. Abbreviations used in NMR spectra are s (singlet), d (doublet), t (triplet), q (quartet), p (pentet), m (multiplet), br (broad) and brs (broad singlet). High resolution mass spectra were taken using Applied BioSystems Mariner BioSpectrometry Workstation oaTOF mass spectrometer. Elemental analysis data were obtained using Carlo Erba CHNS-O EA1108 elemental analyzer.

(171) General Procedure for the Hydrogenation of Solid Amides

(172) The amide (5.0 mmol) was added to a stainless steel autoclave equipped with a magnetic stir bar. 4.0 mL of freshly distilled anhydrous THF was then added to the autoclave using a gas tight syringe. The atmosphere in the autoclave was flushed with H.sub.2 (˜2 atm for 3 min) at RT before adding the 1.0 mL THF solution of the catalyst precursor by cannula under H.sub.2 pressure (˜2 atm). Any residue in the NMR tube and cannula was washed into the autoclave with 3.0 mL of THF. The autoclave was then pressurised to 50 atm with H.sub.2 and the reaction mixture stirred at 100° C. for 23 h. The autoclave was then allowed to cool to RT over 1 h before being vented slowly. MeOH was used to dissolve any precipitated products. The reaction yields were determined by .sup.1H NMR spectroscopy.

(173) General Procedure for the Hydrogenation of Liquid Amides

(174) 4.0 mL of freshly distilled anhydrous THF was added to a stainless steel autoclave equipped with a magnetic stir bar. The atmosphere of the steel autoclave was the flushed with H.sub.2 (˜2 atm for 3 min) at room temperature. During this venting time a solution of the amide (5.0 mmol) in 1.0 mL of THF was prepared under Argon. Under H.sub.2 pressure (˜2 atm) the amide solution and 1.0 mL of the catalyst precursor solution were added to the autoclave punctuated by two 1.0 mL THF washes. The autoclave was then pressurized to 50 atm H.sub.2 and the reaction mixture was stirred at 100° C. for 23 h. The autoclave was then allowed to cool to RT over 1 h before being vented slowly. MeOH was used to dissolve any precipitated products. The reaction yields were determined by .sup.1H NMR spectroscopy.

(175) General Procedure for Hydrogenation of Amides Using Isolated (2) or (5) with NaOMe

(176) 2.50 μmol of the ruthenium precursor and 1.25 mmol of NaOMe were weighed out into two respective NMR tubes in a glove box. 1.0 mL of freshly distilled THF was then cannulated into each of these tubes under Argon. The NMR tubes were then shaken for 10 sec at RT and set aside. 25 mmol of the solid amide was then added to a stainless steel autoclave equipped with a magnetic stir bar. 5 mL of freshly distilled THF was then added to the autoclave using a gas tight syringe. The atmosphere in the autoclave was then flushed with H.sub.2 (˜2 atm for 3 min) at RT. The previously prepared 1.0 mL mixtures of the ruthenium catalyst and NaOMe were then sequentially cannulated into the steel autoclave followed by a 5 mL THF wash to remove any lingering residue. The autoclave was then pressurized to 50 atm with H.sub.2 and the mixture stirred at 100° C. for 23 h. The autoclave was then allowed to cool to RT over 1 h before venting slowly. MeOH was used to dissolve any precipitated products. The reaction yields were determined by .sup.1H NMR spectroscopy.

(177) Control Experiment: Ligand Free Hydrogenation

(178) 0.010 mmol of cis-[Ru(CH.sub.3CN).sub.2(η.sup.3-C.sub.3H.sub.5)(COD)]BF.sub.4 (4), and 0.030 mmol of [(CH.sub.3).sub.3Si].sub.2NK were weighed out into two respective NMR tubes in a glove box. 1.0 mL of freshly distilled THF was then cannulated into each of these tubes under Argon. The 1.0 mL THF mixture of cis-[Ru(CH.sub.3CN).sub.2(η.sup.3-C.sub.3H.sub.5)(COD)]BF.sub.4, (4) was then heated in a water bath at 60° C. with periodic shaking to dissolve the solid. The two NMR tubes were then set aside at RT. 0.10 mmol of the solid amide was then added to a stainless steel autoclave equipped with a magnetic stir bar. The atmosphere in the autoclave was then flushed with H.sub.2 (˜2 atm for 3 min) at RT. The previously prepared 1.0 mL mixtures of the ruthenium precursor and base were then sequentially cannulated into the steel autoclave punctuated by 3.0 mL THF washes to remove any lingering residue in the NMR tubes. The autoclave was then pressurised to 50 atm with H.sub.2 and the mixture stirred at 100° C. for 17 h. The autoclave was then allowed to cool to RT over 1 h before venting slowly. The reaction yields were determined by .sup.1H NMR spectroscopy. Result: No apparent hydrogenation.

(179) Control Experiment: Base Free Hydrogenation

(180) A mixture of cis-[Ru(CH.sub.3CN).sub.2(η.sup.3-C.sub.3H.sub.5)(COD)]BF.sub.4 (4), (0.010 mmol) and 2 equiv of Ph.sub.2PCH.sub.2CH.sub.2NH.sub.2 3, (0.020 mmol) in freshly distilled anhydrous THF (1.0 in L) under Argon was heated in an NMR tube using water bath at 60° C. with periodic shaking for 30 min. The resulting solution was cooled for 1 min to 0° C. using an ice bath before cooling to −78° C. using a dry ice/acetone bath. H.sub.2 (˜2 atm) was cannulated into the NMR tube at −78° C. The tube was then shaken for 10 sec, and promptly returned to the bath. This shaking process was repeated nine times. The resulting yellow solution in the NMR tube was then set aside at −78° C.

(181) The amide (0.10 mmol) was added to a stainless steel autoclave equipped with a magnetic stir bar. 4.0 mL of freshly distilled anhydrous THF was then added to the autoclave using a gas tight syringe. The atmosphere in the autoclave was flushed with H.sub.2 (˜2 atm for 3 min) at RT before adding the 1.0 mL THF solution of the catalyst precursor by cannula under H.sub.2 pressure (˜2 atm). Any residue in the NMR tube and cannula was washed into the autoclave with 3.0 mL of THF. The autoclave was then pressurised to 50 atm with H.sub.2 and the reaction mixture stirred at 100° C. for 17 h. The autoclave was then allowed to cool to RT over 1 h before being vented slowly. The reaction yields were determined by .sup.1H NMR spectroscopy. Result: No apparent hydrogenation.

(182) Control Experiment: Nano-Particle Mediated Hydrogenation

(183) 14.5 mg of Ruthenium Black (0.01 mmol assuming 7% of Ruthenium atoms are on the surface) and 0.10 mmol of the amide were added to a stainless steel autoclave equipped with a magnetic stir bar. The atmosphere in the autoclave was flushed with H.sub.2 (˜2 atm for 3 min) at RT before adding the 8.0 mL of freshly distilled THF by cannula under H.sub.2 pressure (˜2 atm). The autoclave was then pressurised to 50 atm with H.sub.2 and the reaction mixture stirred at 100° C. for 17 h. The autoclave was then allowed to cool to RT over 1 h before being vented slowly. The reaction yields were determined by .sup.1H NMR spectroscopy. Result: 1 turnover (TO) of the substrate to N-cyclohexyl-2-pyrrolidinone. .sup.1H NMR agreed with those reported in the literature. (Y-H. Yang, M. Shi, J. Org. Chem. 2005, 70, 8645.)

(184) Preliminary Studies on the Reactivity of (5) Towards Hydrogen in the Presence of [(CH.sub.3).sub.3Si].sub.2NK in THF-d.sub.8

(185) 0.015 mmol of the catalyst (5) and 0.150 mmol (10 equiv) of [(CH.sub.3).sub.3Si].sub.2NK were weighed out into two respective NMR tubes in a glove box. 0.5 mL of freshly distilled anhydrous THF-d.sub.8 was then cannulated into each of these tubes under Argon. The NMR tubes were then shaken for 10 sec at RT to dissolve the solids before, cooling the solutions to −78° C. using a dry ice/acetone bath. The THF-d.sub.8 solution containing the base was then cannulated in to the catalyst precursor solution using H.sub.2 (˜2 atm) at −78° C. The NMR tube was then shaken for 10 sec, and promptly returned to the −78° C. dry ice/acetone bath. This shaking process was repeated nine times. The resulting orange solution in the NMR tube was then set aside at −78° C. and the atmosphere in the glass autoclave was then flushed with H.sub.2 (˜2 atm for 3 min) at RT.

(186) The previously prepared 1.0 mL THF-d.sub.8 solution was added via cannula using H.sub.2 (˜2 atm). The glass autoclave was then pressurized to 4 atm H.sub.2 and the reaction mixture was stirred at RT for 1 h. At the end of the reaction the autoclave was depressurized to ˜2 atm and an aliquot (0.7 mL) taken immediately for NMR under ˜1 atm H.sub.2.

(187) The reaction was repeated in an NMR tube equipped with a rubber septum using 0.010 mmol of the catalyst precursor, 0.10 mmol (10 equiv) [(CH.sub.3).sub.3Si].sub.2NK and THF-d.sub.8 (0.7 mL, (distilled from Na under Argon) mixed under 1 atm H.sub.2 at −78° C. The reaction was warmed gradually (from −80° C.) in the NMR probe until reaction occurred at 0° C.˜RT.

Example 4

Hydrogenation of Cyclic Amides

(188) .sup.1H NMR Characterization of Hydrogenation Products

(189) For the NMR Spectra of hydrogenation experiments, the peaks are identified by the following legend: Product peaks are notated by (*); Residual solvent peaks are notated by (X); Residual starting material peaks are notated by (.square-solid.); Internal standard peaks are notated by (^); Side product peaks are notated by (+).

(190) Hydrogenation with Catalyst (1)

(191) The activity of (1) in the hydrogenation of N-substituted pyrrolidin-2-ones was tested towards the activated amides N-methylsulfonylpyrrolidin-2-one (2a) and N-acetylpyrrolidin-2-one (2b).

(192) ##STR00028##

(193) The reactivity of (1) was low to moderate. Compound (2a) was hydrogenated in only 27 turnovers (TO) to give the ring-opened N-methanesulfonyl amino alcohol product with 2 mol % Ru in THF (100° C., 50 atm, 20 mol % KOtBu, 39 h). Compound (2b) formed mixtures of pyrrolidine-2-one (major) and the ring-opened N-acetyl amino alcohol in ˜45 TO using 2 mol % Ru (80° C., 50 atm H.sub.2, 20 mol % KN[Si(CH.sub.3).sub.3].sub.2, 16 h). N-phenylpyrrolidin-2-one (2c) did not react under these conditions.

(194) These results contrast the high activity of (1) towards the reduction ketones, esters, and imides in THF. (S. Takebayashi, J. M. John, S. H. Bergens, J. Am. Chem. Soc. 2010, 132, 12832; S. Takebayashi, S. H. Bergens, PCT Int. Pat. Appl. WO 2010/145024 A1, Jun. 17, 2010; R. J. Hamilton, C. G. Leong, G. Bigam, M. Miskolzie, S. H. Bergens, J. Am. Chem. Soc. 2005, 127, 4152; R. J. Hamilton, S. H. Bergens, J. Am. Chem. Soc. 2006, 128, 13700; J. Am. Chem. Soc. 2008, 130, 11979; S. Takebayashi, S. H. Bergens, Organometallics. 2009, 28, 2349.)

(195) Hydrogenation with Catalyst (5)

(196) ##STR00029##

(197) Various lactams were subjected to hydrogenating conditions using catalyst (5). Reactions were performed using in situ prepared catalyst (5). All hydrogenations were carried out with 0.1 mol % Ru, 4-5 mol % KN[Si(CH.sub.3).sub.3].sub.2, 50 atm H.sub.2, 100° C., for 24 h, 5/KN[Si(CH.sub.3).sub.3].sub.2=1:50, [Substrate]=0.626 M in THF. The results are summarized in Table 1. Yield was determined using .sup.1H NMR. The results of these experiments are shown in FIGS. 7-10.

(198) TABLE-US-00001 TABLE 1 Entry Substrate Yield Turnover 1 2c 100 1000 2 2d 5 50 3 2e 0 0 4 6 100 1000 5 7 23 230

(199) N-phenylpyrrolidin-2-one, (2c) was hydrogenated to give N-phenyl-4-aminobutan-1-ol in 100% yield, or 1000 turnover (TO) under these conditions (Entry 1, Table 2). The N-Me ((2d), 50 TO, Entry 2) and N—H ((2e), 0 TO, Entry 3) derivatives were much less active than (2c), while the 6-membered, N-Ph derivative (6) reacted in 100% yield (1000 TO, Entry 4). The 7-membered unsubstituted lactam ((7), 230 TO, Entry 5) was more reactive than the 5-membered lactam (2e) (0 TO, Entry 3), as expected from the greater stability of 5- over 7-membered rings.

(200) Another similar investigation was carried out using N-phenylpyrrolidin-2-one as the substrate with catalyst (5) or (11) and NaOMe as the base. The reactions were performed using in situ prepared catalyst (5) or (11). The reaction conditions were as follows: P(H.sub.2)=50 atm, 100° C., (5) or (11)/NaOMe=1:500, [Substrate]=2.08 M in THF. Yield was determined by .sup.1H NMR. Results are shown in Table 2, below.

(201) ##STR00030##

(202) TABLE-US-00002 TABLE 2 Catalyst Entry Precursor Yield Turnover 1 5 71.2 7120 2 11 67.6 6760

(203) In preliminary experiments, it was found that catalyst (5) reacts with H.sub.2 (˜1 atm) and KN[Si(CH.sub.3).sub.3].sub.2 (˜3 equiv) in THF-d.sub.8 starting at ˜0° C. to form propylene and mainly three Rumono hydrides. (Overlap among the arene, N—H, and aliphatic .sup.1H NMR signals made a conclusive identification impossible. Their reactivity with H.sub.2, and that they are formed from (5) and (2) suggests that they are isomers of the Ru-amide [Ru(H)(Ph.sub.2P(CH.sub.2).sub.2NH.sub.2)—(Ph.sub.2P(CH.sub.2).sub.2NH)] (10). The known dichloride [Ru(Cl).sub.2(Ph.sub.2P(CH.sub.2).sub.2NH.sub.2).sub.2] (2) gives a similar mixture of mono-hydride species under these conditions. (L. Saudan, C. M. Saudan, C. Debieux, P. Wyss, Angew. Chem. Int. Ed. 2007, 46, 7473; L. Saudan, P. Dupau, J. Riedhauser, P. Wyss, PCT Int. Pat. Appl. WO 2006/106484 A1, Oct. 12, 2006; PCT Int. Pat. Appl. WO 2006/106483, Apr. 4, 2006; L. Saudan, C. Saudan, PCT Int. Pat. Appl. WO 2008/065588 A1, Jun. 5, 2008; PCT Int. Pat. Appl. WO 2010/038209 A1, Apr. 8, 2010; L. Saudan, Acc. Chem. Res. 2007, 40, 1309.)

(204) This mixture reacts further (˜4 atm H.sub.2, ˜10 equiv KN[Si(CH.sub.3).sub.3].sub.2) at RT to generate a symmetrical dihydride as major product that is tentatively assigned to be an isomer of trans-[Ru(H).sub.2(Ph.sub.2P(CH.sub.2).sub.2NH.sub.2).sub.2] (9). This preliminary assignment is based upon the similarities between the .sup.31P {.sup.1H} and .sup.1H (hydride) NMR spectra between (9) and (1) (see R. J. Hamilton, C. G. Leong, G. Bigam, M. Miskolzie, S. H. Bergens, J. Am. Chem. Soc. 2005, 127, 4152; R. J. Hamilton, S. H. Bergens, J. Am. Chem. Soc. 2006, 128, 13700; J. Am. Chem. Soc. 2008, 130, 11979). The peaks for compound (9) were assigned using .sup.1H, .sup.31P, gCOSY, .sup.1H-.sup.31P gHSQC and gTOCSY NMR experiments. .sup.31P {.sup.1H} NMR −(161.903 MHz, THF-d.sub.8, 27° C.): 56.2 ppm (s). .sup.1H NMR −(399.951 MHz, THF-d.sub.8, 27° C.): δ −8.26 (Ru—H, t, J=14.8 Hz), δ 1.25, δ 2.43, δ 2.73).

(205) Use of (4) as catalyst precursor, or (5) without added base (both at 10 mol %), did not result in hydrogenation. Further, use of Ru black (10 mol %) resulted only in hydrogenation of the arene ring in (2c). It is therefore unlikely that Ru nanoparticles are the active catalyst in these hydrogenations.

(206) Saudan et al. reported that (2) forms an active ester hydrogenation catalyst with NaOMe as base in THF. (L. Saudan, C. M. Saudan, C. Debieux, P. Wyss, Angew. Chem. Int. Ed. 2007, 46, 7473; L. Saudan, P. Dupau, J. Riedhauser, P. Wyss, PCT Int. Pat. Appl. WO 2006/106484 A1, Oct. 12, 2006; PCT Int. Pat. Appl. WO 2006/106483, Apr. 4, 2006; L. Saudan, C. Saudan, PCT Int. Pat. Appl. WO 2008/065588 A1, Jun. 5, 2008; PCT Int. Pat. Appl. WO 2010/038209 A1, Apr. 8, 2010; L. Saudan, Acc. Chem. Res. 2007, 40, 1309.) Indeed, it was found that (5) and (2) (0.01 mol %) both hydrogenate (2c) in a remarkable 7120 and 6760 TO respectively in the presence of 5 mol % NaOMe (see Table 2).

Example 5

Proposed Mechanism for Hydrogenation of Amides

(207) Again, while not wishing to be bound by theory, the following mechanism for the hydrogenation of amides with (9) (Scheme 2, below) is proposed. The first step is a bifunctional type addition of amide to (9) forming the Ru-(hemiaminaloxide) (12) as the net product. Base assisted elimination from (12) forms the Ru-amide (10), and the free hemiaminaloxide (13) which regenerates the base and eliminates aldehyde and H—NR.sup.1.sub.2. Addition of H.sub.2 to (10) regenerates (9) and hydrogenation of the aldehyde forms the alcohol. Consistent with this mechanism is the formation of benzyl benzoate by the Tishchenko reaction of benzaldehyde during the hydrogenation of (8a) (Table 3).

(208) ##STR00031##

(209) Catalysts (5) and (2) are active towards the hydrogenation of a series of amides without strongly activating functional groups. Significantly, the commonly inert, unfunctionalized amide dimethyl acetamide was hydrogenated in 500 turnover, and N-phenylpyrrolin-2-one was hydrogenated in up to 7120 turnover.

Example 6

Hydrogenation of Acyclic Amides

(210) ##STR00032##

(211) An investigation was carried out with an acyclic amides using (5) and KN[Si(CH.sub.3).sub.3].sub.2. The reactions were performed using in situ prepared catalyst (5). The reaction conditions were as follows: P(H.sub.2)=50 atm, 100° C., 5/KN[Si(CH.sub.3).sub.3]=1:40, [Substrate]=0.626 M in THF. Yield was determined by .sup.1H NMR. For entry 1, the yield comprised 72% Benzyl Alcohol and 14% Benzyl Benzoate. For substrate (8i), anthracene was used as an internal standard. The results of these experiments are shown in FIGS. 11-20 and in Table 3.

(212) TABLE-US-00003 TABLE 3 Substrate R R.sup.1 R.sup.2 Yield (%) Turnover 8a Ph Ph Ph 100 1000 8b Ph Ph Me 96 960 8c Ph Me Me 50 500 8d Ph —(CH.sub.2).sub.5— — 82 820 8e Ph Ph H 50 500 8f Ph Me H 27 270 8g Me Ph Ph 100 1000 8h Me Ph Me 100 1000 8i Me Me Me 50 500 8j Me Ph H 70 700

(213) As shown in Table 3, the order of reactivity among the acyclic benzamides was —N(Ph).sub.2 (1000 TO) ˜—N(Ph)Me (960 TO)>—N(Me).sub.2 (500 TO) (Substrates (8a)-(8c)). This order is consistent with the differences in the extent of donation from the lone pair on nitrogen to the carbonyl carbon among these substrates. 1-Benzoylpiperidine (820 TO, Substrate (8f) was more active than (8c) (500 TO), while secondary amides were somewhat less reactive than tertiary amides —N(Ph)H (500 TO, Substrate (8e)) vs —N(Ph).sub.2 (1000 TO, Substrate (8a)), and —N(Me)(H) (270 TO, Entry 6) vs —N(Me).sub.2 (500 TO, Substrate (8c)). Similar results were obtained with acyclic acetamides. Specifically, —N(Ph).sub.2 (1000 TO) ˜—N(Ph)Me (1000 TO)>—N(Me).sub.2 (500 TO) (Substrates (8g) and (8h)). The secondary acetamide —N(Ph)H (700 TO, Substrate (8j)) was less reactive than the corresponding tertiary amide (1000 TO, Substrate (8h)). The lower reactivity of secondary- vs tertiary-amides may arise from reaction of the secondary amide with the added base.

Example 7

Base Free Hydrogenation

(214) Base-free conditions are desirable in order to carry out hydrogenations of amides that contain functional groups that are sensitive to base, and to carry out certain enantioselective amide reductions. Compound (5) will react with 2 equivalents (Ru:B=1:2) in THF to generate a catalyst that is active for amide hydrogenations in the absence of added strong base.

Example of In Situ Catalyst Generation Using [Ru(η3-C3H5)(Ph2PCH2CH2NH2)2]—BF4, (5), and 2 Equiv. NaBH4

(215) ##STR00033##

(216) 0.02 mmol (13.7 mg) of [Ru(η.sup.3-C.sub.3H.sub.5)(Ph.sub.2PCH.sub.2CH.sub.2NH.sub.2).sub.2]BF.sub.4 (5) and 0.04 mmol (1.5 mg) of NaBH.sub.4 were weighed out into two separate NMR tubes in a glove box. This was immediately followed by the addition of 1.0 mL of freshly distilled THF to the NMR tube containing the ruthenium precursor. The contents of this NMR was then cannulated under ˜2 atm H.sub.2 into the NMR tube containing NaBH.sub.4. The mixture was then heated at 60° C. for 20 min with periodic shaking. During this time the color of the solution intensified. At the same time, 1.0 mmol (0.1972 g) of benzanilide was added to a high pressure steel autoclave and the autoclave purged with H.sub.2 for 20 min. 5 mL of fresh anhydrous THF was then cannulated into the steel autoclave followed by the 1 mL catalyst THF solution and a 2 mL THF wash. The high-pressure steel autoclave was then heated and pressurized to 100° C. and 50 atm of H.sub.2 for 66 h. The autoclave was then allowed to cool to room temperature over the course of 1 h before taking an aliquot of the homogenous solution for .sup.1H NMR. Results are shown in Table 4, below. All percentage conversions were determined using .sup.1H NMR.

(217) TABLE-US-00004 TABLE 4 Temperature Pressure Time Conversion Entry (° C.) (atm H.sub.2) (h) (%) Turnover l.sup.a 100 50 67 100 50 2.sup.b 50 50 24 0 0 3.sup.a 22 50 23 0 0 .sup.aPerformed using 2 mol % Ru in 8 mL of THF. .sup.bPerformed using 0.1 mol % Ru in 10 mL of THF.

(218) In some cases, the base-free catalyst is more active (or of comparable activity) than systems that employ the added strong base {KN[Si(CH.sub.3).sub.3].sub.2}. The results that employ the use of this base (called base-assisted) are shown for comparison.

(219) Substrate Screening

(220) Base free conversions were carried out using 0.1 mol % Ru: [Ru(η.sup.3-C.sub.3H.sub.5)(Ph.sub.2PCH.sub.2CH.sub.2NH.sub.2).sub.2]BF.sub.4 (5) and 2 equiv. of NaBH.sub.4 in 10 mL THF at 100° C. and 50 atm H.sub.2 for 24 h. The base assisted hydrogenations were performed using 0.1 mol % in situ prepared [Ru(η.sup.3-C.sub.3H.sub.5)(Ph.sub.2PCH.sub.2CH.sub.2NH.sub.2).sub.2]BF.sub.4 (5). Reaction Conditions 50 atm H.sub.2, [Ru(η.sup.3-C.sub.3H.sub.5)—(Ph.sub.2PCH.sub.2CH.sub.2NH.sub.2).sub.2]BF.sub.4 (5)/K[N[Si(CH.sub.3).sub.3]=1:40, [substrate]=0.626 M in THF. For the hydrogenation of dimethylacetamide, anthracene was used as an internal standard. (See: John, J. M.; Bergens, S. H. Angew. Chem. Int. Ed. 2011, 50, 10377.) All percentage conversions were determined using .sup.1H NMR. Results are shown in Table 5, below.

(221) TABLE-US-00005 TABLE 5 Base Base Free Base Assisted Base Conversion Free Conversion Assisted Substrate Product (%) Turnover (%) Turnover 91 913 100 1000 100 1000 100 1000 93 935 100 1000 0 96 964 no data no data 80 806 70 700 24 248 50 500

Example of In Situ Catalyst Generation Using [Ru(η3-C3H5)(Ph2PCH2CH2NH2)2]—BF4, (5), and 2 Equiv. NaBH4

(222) Method was performed as above except for one modification. The high-pressure steel autoclave was heated and pressurized to 100° C. and 50 atm of H.sub.2 for 23 h. The autoclave was then allowed to cool to room temperature over the course of 1 h before taking an aliquot of a homogenous solution for .sup.1H NMR.

Example 8

Precursor Screening

(223) It was desirable to find a Ru-containing precursor that could reliably generate the active catalyst for P—P, P—N, and related ligand types. This screening experiment demonstrates that both [Ru(COD)(Anthracene)]BF.sub.4 (3), and [Ru(η.sup.3C.sub.3H.sub.5)(COD)(MeCN).sub.2)]BF.sub.4 (4), can generate in situ catalysts of similar, high activity using the ligand Ph.sub.2P(CH.sub.2).sub.2NH.sub.2 under base-free conditions.

(224) ##STR00046##

Example In Situ Catalyst Generation from [Ru(COD)(Anthracene)]BF4, (3)

(225) 0.02 mmol (9.5 mg) of [Ru(COD)(Anthracene)]BF.sub.4 (3), and 0.10 mmol (3.8 mg) of NaBH.sub.4 were weighed out into two separate NMR tubes in a glove box. 0.04 mmol (9.2 mg) of Ph.sub.2PCH.sub.2CH.sub.2NH.sub.2 was then added to the NMR tube containing the Ruthenium precursor via a syringe. This was immediately followed by the addition of 1.0 mL of freshly distilled THF. The NMR tube was then heated at 60° C. for 30 min with periodic shaking. The light yellow solution was then cannulated under ˜2 atm H.sub.2 into the NMR tube containing the solid NaBH.sub.4. The mixture was then heated at 60° C. for 20 min during which the color of the solution because more intense. At the same time, 20.0 mmol (3.2216 g) of N-phenylpyrrolidinone was added to a high pressure steel autoclave and the autoclave purged with H.sub.2 for 20 min. 5 mL of fresh anhydrous THF was then cannulated into the steel autoclave followed by the 1 mL catalyst THF solution and a 4 mL THF wash. The high-pressure steel autoclave was then heated and pressurized to 100° C. and 50 atm of H.sub.2 for 23 h. The autoclave was then allowed to cool to room temperature over the course of 1 h before taking an aliquot of the homogenous solution for .sup.1H NMR. The results are shown in Table 6.

(226) TABLE-US-00006 TABLE 6 Ru:Ph.sub.2P(CH.sub.2).sub.2NH.sub.2: Temp Pressure Time Conversion Ruthenium Precursor NaBH.sub.4:Substrate (° C.) H.sub.2 (atm) (h) (%) Turnover [Ru(COD)(Anthracene)]BF.sub.4 1:2:5:1000 100 50 24 66 660 [Ru(η.sup.3-C.sub.3H.sub.5)(COD)- 1:2:5:1000 100 50 24 71 710 (MeCN.sub.2)]BF.sub.4

Example 9

Chiral Hydrogenation

(227) α-Chiral amide hydrogenations can be carried out using the present catalysts. An enantioselective amide hydrogenation that proceeds via a dynamic kinetic resolution at the carbon α-to the amide group has been investigated. In summary, the α-carbon in the substrate (shown below) is chiral. This C—H bond on this carbon centre is also weakly acidic, and rapidly racemizes in the presence of excess base during the catalytic hydrogenation. (dach=1,2-diaminocyclohexane)

(228) ##STR00047##

(229) In these reactions, the excess base is 30% KOtBu. The C—H bond in the product alcohol is not acidic, and the carbon centre does not racemize in the product. Thus, a chiral catalyst can, in principle, hydrogenate one enantiomer of the above substrate to generate one enantiomer of the product. The leftover starting amide replenishes the reacted enantiomer via the base-catalyzed racemization, and so on, until all is converted into one enantiomer of the product alcohol.

(230) These hydrogenation reactions, carried out with excess base, can proceed under conditions as mild as 0° C. under pressures as low as 4 atm H.sub.2. Such conditions are extremely mild compared to those previously found, which often require high pressures of H.sub.2 and high temperatures to proceed. The catalyst loadings used for these reactions were higher than those used with base.

(231) General Procedure for the Hydrogenation of α-Chiral Amide Using RuCl.sub.2{(R,R)(Ph.sub.2PCH(Ph)CH(Me)NH.sub.2}.sub.2

(232) 0.01 mmol (8.1 mg) of RuCl.sub.2{(R,R)(Ph.sub.2PCH(Ph)CH(Me)NH.sub.2}.sub.2 (12a), and 0.15 mmol (16.8 mg) of KOtBu were weighed out into two separate NMR tubes in a glove box. 1 mL of freshly distilled THF was then added to each of the NMR tubes and then shaken to dissolve the compounds. A low-pressure glass reactor was then charged with 0.5 mmol of amide and then purged for 10 min with H.sub.2. The catalyst precursor solution was then cannulated into the reactor under H.sub.2 followed by KOtBu solution and a 2 mL THF wash. The reactor was then pressurized to 4 atm H.sub.2. The reaction was then monitored every 20 min by removing a sample and recording the .sup.1H NMR.

(233) Several amides and catalysts have been screened using this reaction, and determined the enantiomeric excess of the product alcohols. The data obtained is summarized in table 7, below. Percentage conversion was determined by .sup.1H NMR. Percentage enantiomeric excess (ee) was determined by HPLC using CHIRALPAK TM IB Column, reaction conditions: 4 atm H.sub.2, room temperature (22° C.), [Substrate]=0.125 M (4 mL THF).

(234) TABLE-US-00007 TABLE 7 Temperature Time Conversion ee Catalyst (° C.) (min) (%) (%) 11a 22 20 100 58 11a  0 100 100 60 11b 22 20 100 54 11c 22 20 100 63 11d 22 80 100 57 11e 22 100 100 18 12a 22 30 100 1 12a −80-22 1020 0 0

(235) Substrate 1

(236) The reaction conditions were carried out substantially as described above. The specific conditions for this experiment were: 4 atm H.sub.2, room temperature (22° C.), [Substrate]=0.125 M (4 mL THF). Results are shown in Table 8.

(237) ##STR00048##

(238) TABLE-US-00008 TABLE 8 Catalyst Substrate Temperature (° C.) Time (h) Conversion (%) ee (%) 11a 22 4 100 Near zero 12a 0 22 2 100 Near zero

(239) Substrate 2

(240) The reaction conditions were carried out substantially as described above. The specific conditions for this experiment were: 4 atm H.sub.2, room temperature (22° C.), [Substrate]=0.125 M (4 mL THF). Results are shown in table 9, below.

(241) ##STR00051##

(242) TABLE-US-00009 TABLE 9 Temperature Time Conversion ee Catalyst Substrate (° C.) (h) (%) Turnover (%) 12a 22 22 69 35 no data  9 22 22 55 30 no data

(243) Substrate 3

(244) The reaction conditions were carried out substantially as described above. The specific conditions for this experiment were: 4 atm H.sub.2, room temperature (22° C.), [Substrate]=0.025 M (4 mL THF). Results are shown in table 10, below.

(245) ##STR00054##

(246) TABLE-US-00010 Table 10 Temperature Time Conversion Catalyst Substrate (° C.) (h) (%) 12a 22 1 100  9 22 2 100

(247) All publications, patents and patent applications mentioned in this Specification are indicative of the level of skill of those skilled in the art to which this invention pertains and are herein incorporated by reference to the same extent as if each individual publication, patent, or patent application was specifically and individually indicated to be incorporated by reference.

(248) The invention being thus described, it will be obvious that the same may be varied in many ways. Such variations are not to be regarded as a departure from the spirit and scope of the invention, and all such modifications as would be obvious to one skilled in the art are intended to be included within the scope of the following claims.